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Mast cells are located in mucosal and connective tissues throughout the body 
where they play important roles in immune reactions towards infections. Mast cell 
deficiency results in failure of clearance of the non-invasive intestinal protozoan 
parasite Giardia intestinalis in mice, but the mast cell-driven mechanisms remain 
poorly understood. It is well known that pathogen-activated mast cells can release 
large number of inflammatory mediators, including the mast cell specific proteases 
and the serglycin (SG) proteoglycan. In this thesis the functional roles of the SG-
dependent mast cell proteases tryptase and chymase during G. intestinalis were 
addressed, both in vitro and in vivo. 
In vitro, soluble Giardia proteins (sGPs) were demonstrated to stimulate mucosal-
like mast cells to release IL-6 and tryptase, and both sGPs and excretory-secretory 
proteins (ESPs) were found to enhance human and mouse tryptase activity, but in 
contrast sGPs inhibited chymase activity. These finding suggest that proteins 
secreted by Giardia can modulate the activity of both chymase and tryptase.  
In vivo, oral gavage with Giardia trophozoites was performed to challenge 
chymase mMCP-4-deficient as well as SG-deficient mice. Clinical scoring and 
weight data were recorded in a blinded fashion. Fecal samples collected from 
individual mice every second day were evaluated with nested PCR to confirm 
successful Giardia infection. The small intestines, serum and tail tissue were 
sampled from each mice and evaluated for: cytokine and chemokine expression, 
morphological changes and genotype. Infection of mature adult mice with G. 
intestinalis caused a more rapid significant weight loss in the mMCP-4-deficient 
than in the mMCP-4
+/+
 mice. In young SG-deficient female mice the infection with 
G. intestinalis caused a significantly reduced weight gain, suggesting a sex- and 
SG-dependent response to the infection. Serum levels of IL-6 matched the weight 
changes in both the mMCP-4 and the SG mouse strains. A regulatory role of 
mMCP-4 and SG, respectively on the intestinal inflammatory cytokine responses 
was indicated by real-time PCR. Furthermore, increased numbers of intestinal 
goblet cells and granulocytes, unaltered myeloperoxidase activity and a decreased 
neutrophil elastase activity were found in the G. intestinalis-infected mice, 
suggesting that secreted Giardia proteins can also modulate neutrophil protease 
activities.  
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proteoglycan, Giardia intestinalis, excretory-secretory proteins (ESPs), soluble 
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Abstract 
  
Mastceller sitter strategiskt placerade kroppen, framförallt i slemhinnor och 
bindväv nära “utsidan”, och kan snabbt svara på angrepp av patogener genom att 
starta det medfödda immunsvaret. Mastceller har visats vara viktiga för att 
bekämpa infektion med den icke invasiva intestinala protozo-parasiten Giardia 
intestinalis, men de mastcells-drivna mekanismerna är fortsatt oklara. Vid 
infektion aktiveras mastceller och frisätter en mängd inflammatoriska mediatorer, 
till exempel mastcell-specifika proteaser och serglycin (SG) proteoglykaner. Här 
undersökte jag vilken roll de SG-beroende mastcellsproteaserna kymas och tryptas 
har vid infektion med G. intestinalis. 
Mukosa-liknande mastceller stimulerade med lösliga Giardia proteiner (sGPs) in 
vitro frisatte IL-6 och små mängder tryptas. Både sGPs och “excretory-secretory 
proteins” (ESPs) förstärkte den enzymatiska aktiviteten hos tryptas, medan kymas-
aktiviteten inhiberades vid interaktion med sGPs, vilket indikerar att utsöndrade 
proteiner från Giardia kan modulera aktiviteten av kymas och tryptas. 
In vivo studerades de SG-beroende mastcellsproteaserna via gavage-challenge med 
G. intestinalis trophozoiter i kymas-defekta (mMCP-4
-/-
) och serglycin-defekta 
(SG
-/-
) möss. I helt blindade försök noterades viktdata och djurens allmänna 
hälsotillstånd. Feces insamlades för att påvisa Giardia DNA med “nested PCR” 
vilket konfirmerade att de experimentella infektionerna fungerade. Vid 
experimentets avslut insamlades tunntarm, serum och svansvävnad för bestämning 
av uttrycket av cytokiner och kemokiner, morfologiska förändringar samt 
bestämning av mössens genotyp. Infektion med G. intestinalis gav en snabbare 
viktminskning i vuxna mMCP-4
-/-
 än i mMCP-4
+/+
 möss. Infektion med G. 
intestinalis i unga möss gav ett signifikant avbrott i viktökning framförallt hos de 
SG
-/-
 honmössen, vilket indikerar ett köns- och SG- beroende svar mot infektionen. 
IL-6 nivåerna i serum matchade viktförändringarna i mMCP-4 och SG 
musstammarna. Det inflammatoriska svaret i tarmen och den potentiella 
reglerande rollen av kymas och SG utvärderades med qPCR. Vid infektion med G. 
intestinalis ökade antalet bägarceller och granulocyter i tarmen. Myeloperoxidas-
aktiviteten var oförändrad medan neutrofilelastas-aktiviteten minskade vilket 
indikerar att utsöndrade Giardia proteiner också kan modulera aktiviteten hos 
neutrofila proteaser.  
Key words: mast cell proteases, chymase/mMCP-4, tryptase/mMCP-6, serglycin 
proteoglycan, Giardia intestinalis, excretory-secretory proteins (ESPs), soluble 
Giardia proteins (sGPs) 
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Serglycin-dependent mast cell-specific proteases and 
their potential interactions with Giardia intestinalis 
1 Introduction: 
Mast cells are traditionally known for their role in allergic reactions but 
have lately also been recognized for their importance in the immune 
response against several infectious diseases. Because of their location in 
mucosal and connective tissues mast cells can affect the inflammatory 
response and immunity during intestinal parasitic infections such as 
Giardia intestinalis that causes the diarrheal disease giardiasis. Giardia 
intestinalis is a non-invasive intestinal protozoan parasite, i.e. it stays 
attached to the luminal side of the epithelium of the small intestine. In the 
intestine G. intestinalis secretes antigens and modulatory proteins that 
influence both the innate and the adaptive immune reactions of the host. In 
line with this the clearance of G. intestinalis in mice requires mast cells, 
but the exact mechanisms by which mast cells combat G. intestinalis 
remain poorly understood. Activation of mast cells can cause release of a 
large number of preformed secretory granule-stored inflammatory 
mediators. These mediators include the mast cell-specific proteases (i.e. 
tryptase and chymase) and the proteoglycan serglycin (SG) that is essential 
for storage of the proteases. In the present thesis the functional role of mast 
cell specific proteases in giardiasis is addressed. For that purpose, a 
combination of in vivo and in vitro experimental models has been applied 
including mouse strains deficient in SG or in the chymase murine mast-cell 
protease-4 (mMCP-4).  
1.1 Mast cells in the immune system 
Mast cells execute important roles during the immune response, 
particularly during the innate immune responses. Immature progenitor 
mast cells, derived from hematopoietic stem cells in the bone marrow, 
circulate in the blood before extravasation and final differentiation and 
maturation in the tissue. Mast cells are widely distributed throughout the 
body, especially in connective and vascular tissues of the skin, airway and 
digestive tract, as well as in mucosal tissues. Mast cells usually reside 
12 
 
close to blood vessels, nerves, smooth muscles, secretory glands and hair 
follicles. With this location mast cell-degranulation and release of potent 
inflammatory mediators will have immediate effects on the surrounding 
tissue. Classical activation of mast cells is via crosslinking of the 
IgE/FcRI-receptor complex, but mast cells can be activated by many other 
stimulus, e.g. by toxins (like snake venom), complement components, 
alarmins (like IL-33), as well as by physical damage caused by high 
temperature, ionizing radiation and trauma. The released mast cell-
mediators will participate in many different aspects of the immune 
responses, e.g. regulating the recruitment and activation of neutrophils, 
eosinophils, macrophages, and affecting some activities of T-cells and B-
cells (Cardamone et al. 2016).  
1.2 Mast cell mediators 
Mature tissue resident mast cells produce and store large amounts of highly 
reactive preformed mediators such as histamine, SG proteoglycans (PGs), 
and the mast cell-specific proteases in their inducible secretory granules. 
After mast cell-activation leading to degranulation these mediators are 
released causing instant changes in the tissue. In addition, within minutes 
after activation mast cells start to synthesize eicosanoids and within hours 
post activation mast cells secrete newly synthesized cytokines and 
chemokines. Here follows a short description of some of these mediators. 
1.2.1 Mast cell proteases 
Tryptases and chymases, and to some extent carboxypeptidase A3 (CPA), 
are considered as mast cell-specific proteases, but their expression patterns 
are dependent on the species. In humans, mast cells can be divided into 
two subclasses: “MCT” expressing tryptase only and “MCTC” expressing 
tryptase, chymase and CPA3. Similarly, rat and mouse connective tissue 
mast cells (CTMCs) express tryptases, chymases and CPA3, while rodent 
mucosal mast cells (MMCs) expresses chymases only (Pejler et al. 2007). 
1.2.2 Mast cell tryptases 
Mast cells express at least four different tryptase genes, i.e the α-, β-, γ-, δ-
tryptase genes. Of these the α- and β-tryptases are probably the most 
abundant proteases expressed by mast cells. The α-tryptase can be further 
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classified into αІ- and αІІ-tryptase and the β-tryptases into βІ-, βІІ- and 
βІІІ-tryptase (Miller et al. 1990; Pallaoro et al. 1999). α-tryptases and β-
tryptases are usually forming tetrameric serine proteinases, with their 
monomer active catalytic sites facing inwards, forming a rather narrow 
proteasome-like central pore that only allows entry of linear peptides. 
However, β-tryptases, which can exist both as monomers and tetramers, 
appear to be the main form of tryptase stored in mast cell-granules. 
Tetramerization of tryptase monomers occurs only when pH values are 
below 6.5 (Hallgren and Pejler 2006; Hallgren et al. 2000), suggesting that 
once released into the tissue with pH ≈7 it will dissociate into monomers.  
Tryptase constitutes approximately twenty percent of the protein content in 
human mast cells (Abraham 2002; McEuen et al. 1996). It has been 
suggested as a valid marker for mast cell-activation and to play crucial 
roles in inflammatory diseases or during infections. For instance, mast cell 
tryptase secretion and tryptase-positive mast cells are increased in patients 
with ulcerative colitis or irritable bowel syndrome (Raithel et al. 2001; 
Sohn et al. 2014). In mice, secretion of the orthologous β-tryptase mMCP-
6 comprises an integral link in the chronic immune response, contributing 
to eosinophil recruitment in striated muscle tissue during infection with the 
parasitic nematode Trichinella spiralis (Shin et al. 2008). In addition, 
mMCP-6 is needed for full-blown airway hyper-responsiveness (Cui et al. 
2014) and is highly expressed in airway mast cells after exposure to 
cigarette smoke (Mortaz et al. 2012). Another isoform of mouse β-tryptase, 
mMCP-7, showed up-regulated expression after induction of activin A and 
transforming growth factor-beta 1(TGF-beta 1) (Funaba et al. 2003; 
Funaba et al. 2006). Recombinant mMCP-7 can initiate angiogenesis in 
vitro in matrix gel embedded endothelial cells by degrading the integrin 
subunits v and β1 (de Souza Junior et al. 2019).   
1.2.3 Mast cell chymases 
The monomeric human chymase, with the substrate-binding pocket located 
on the “surface”, is exclusively expressed by CTMCs and was isolated 
already in 1959 (Benditt and Arase 1959). Chymases are classified into α- 
and β-chymases and while humans only express one α-chymase (Caughey 
et al. 1991) mouse MMCs express two β-chymases, i.e. mMCP-1 and 
mMCP-2 whereas mouse CTMCs mainly express one β-chymase mMCP-4 
and one α-chymase mMCP-5 (Huang et al. 1991; Reynolds et al. 1990). 
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An evolutionary phylogenetic comparison based on nucleotide and protein 
sequences of human chymase vs the mouse chymases suggested that the 
mouse chymase mMCP-5 is orthologous to the human chymase. However, 
functional studies of mMCP-4 and mMCP-5 revealed that the mMCP-4 
chymase is the closest functional orthologue to human chymase, in terms 
of extended substrate specificity and tissue location (reviewed by (Pejler et 
al. 2007). In contrast, the mouse chymase mMCP-5 chymase was shown to 
have elastolytic activity (Karlson et al. 2003; Thorpe et al. 2018). 
The storage of very high levels of active chymase in human mast cells 
suggests that this mast cell-specific protease exerts a major role in mast 
cell-mediated diseases (Krishnaswamy et al. 2001). The chymases are 
mainly released after mast cell degranulation, and the human chymase 
enables microvascular leakage in the skin and promotes tissue 
accumulation of inflammatory cells (He and Walls 1998a, 1998b). Human 
chymase also cleave the cytokines IL-1, -15, -18 and -33 (Fu et al. 2017), 
and degrade cell to cell junction molecules, e.g. occludin, claudin-4, ZO-1 
and E-cadherin in epithelial cells (Zhou et al. 2018). In experimental 
infections in mouse models, expression of the mucosal chymase mMCP-1 
is up-regulated in the jejunum after infection with Nippostrongylus 
brasiliensis (Scudamore et al. 1997) and clearance of the nematode T. 
spiralis is delayed in mice lacking mMCP-1 (Knight et al. 2000). The 
other mucosal chymase mMCP-2 is also expressed and released by MMCs, 
but to date very little is known about the biological function of mMCP-2 
(Pemberton et al. 2003). For the murine CTMC-proteases the chymase 
mMCP-4 has three functions; degrade the alarmins heat shock protein 70, 
biglycan, HMGB1, IL-33 (Roy et al. 2014) and TNF- (Piliponsky et al. 
2012), activate pro-matrix metalloproteinase (MMP)-2 and pro-MMP-9 
(Tchougounova et al. 2005), and inactivate thrombin (Pejler and Karlstrom 
1993; Tchougounova 2003). These studies all suggest an important role of 
the chymase mMCP-4 and, by using the mouse knockout model, it has 
been shown that chymase/mMCP-4 contributes to various disease 
conditions (see Table 1 for some examples). The elastase mMCP-5 is 
much less well studied in disease settings but seem to contribute to 
ischemia-reperfusion injury of mouse skeletal muscle (Abonia et al. 2005), 
to wound healing after skin burn injury (Younan et al. 2010; Bankova et al. 
2014), and to the inflammatory levels in experimental rheumatoid arthritis 
(Stevens et al. 2017). 
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Table 1. Mast cell chymase mMCP-4 associated diseases 
Diseases  Comments  References 
Myocardial 
infarction 
 mMCP-4 not only protects heart function and 
survival but also alleviates cardiac dysfunction.  
mMCP-4 could degrade insulin-like growth factor-
1 (IGF-1) to promote cell death.  
 (Houde et al. 2018; 
Wang et al. 2019; Tejada 
et al. 2016) 
 
Traumatic spinal 
cord 
 mMCP-4 plays protective role in traumatic spinal 
cord damage by cleaving MCP-1, IL-6, IL-13 and 
by suppressing scar formation 
 (Vangansewinkel et al. 
2019; Nelissen et al. 
2014) 
Melanoma 
colonization 
In a mouse model with a triple knockout of CPA, 
mMCP-4 and mMCP-6 melanoma colonization of 
the lungs was increased 
(Grujic et al. 2017) 
Atherosclerosis   Inhibition of mMCP-4 reduces lesion spreading 
and helps stabilization of the advanced plaque 
 (Houde et al. 2016) 
Wound healing  mMCP-4, together with mMCP-5 and mMCP-6, 
plays a critical role in microdeformational wound 
therapy in the proliferative phase of healing 
 (Succar et al. 2014) 
Lung 
inflammation 
 Inflammation and fibrosis levels in bleomycin-
induced lung inflammation are reduced in mice 
with a genetic deletion of mMCP-4 
 (Reber et al. 2014) 
Epidermal injury  mMCP-4 disrupts the tight junction claudin-4 to 
mediate epidermal injury  
 (Bankova et al. 2014) 
Sepsis   mMCP-4 partly enhances survival of sepsis by 
degrading Tκand limiting inflammation. 
 (Piliponsky et al. 2012) 
Skin tumour During tumour progression, the expression of CPA 
and other mast cell proteases increased. 
(de Souza et al. 2012) 
Bullous 
pemphigoid 
 mMCP-4 cause activation of MMP-9 and 
degradation of the transmembrane protein BP180 
leading to blisters by detaching the basement 
membrane from the cornified skin 
 (Lin et al. 2011) 
Autoimmune 
arthritis 
 mMCP-4 null mice immunized with collagen II 
shows less cartilage destruction, pannus formation 
and mononuclear cell infiltration 
 (Magnusson et al. 
2009) 
Venom The release of mast cells CPA3 and other 
proteases can enhance innate defense by 
degradation of snake and honeybee toxins, e.g. 
endothelin, sarafotoxin. 
(Akahoshi et al. 2011; 
Rivera 2006; Metz et al. 
2006; Schneider et al. 
2007) 
Scleroderma   The chymase inhibitor SUN-C8257 reduces the 
upregulated mMCP-4 expression during the 
development of skin fibrosis 
 (Kakizoe et al. 2001; 
Shiota et al. 2005) 
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 in  inflammation (Nissinen  and  Kahari  2014) and  can  directly  affect  the
degrade  extracellular  matrix  components.  In  disease,  MMPs  are  involved 
as  pathological  situations.  The  major  functional  roles  of  MMPs  are  to 
only expressed by mast cells, are implicated in many physiological as well 
(Ronnberg et  al. 2013;  Ronnberg et  al. 2014). The MMPs,  which  are  not 
mast  cells  and  granzyme  H  in  human  mast  cells  were  recently  described
extravasation (Pardo et al. 2007). The expression of granzyme D in murine 
2017),  cause  cell  death,  increase  vascular  permeability  and  leukocyte 
can  decrease  efficacy  of  anti-angiogenic  therapy (Wroblewski et  al. 
express  a  few granzymes, i.e. granzyme  B,  D  and  H,  where  granzyme  B 
(Jahanyar et al. 2007; Helske et al. 2006; Lewicki et al. 2018). Mast cells 
cell-expressed  cathepsin  G  has  been  associated  with  heart  diseases
levels  of  CPA3 protein  and  activity (Henningsson et  al. 2003) and  mast 
(MMPs). In bone marrow derived mast cells cathepsin C and S regulate the 
proteases  cathepsins,  as  well as  granzymes  and matrix  metalloproteinases
Mast  cells  can  also express  other  proteases, e.g. several  of  the  aspartic 
1.2.5 Other proteases expressed in mast cells
(Schneider et al. 2007).
enzymatically  dead  CPA3  and  retains  a  normal  level  of  active  mMCP-5
CPA3 is  inactivated,  was  developed.  This  mouse  strain  makes  an 
another  CPA3 knockout  mouse  strain,  in  which  the  enzymatic  activity 
studying the complex aspects of CPA3 function in vivo. To counteract this, 
Based  on  this,  the  CPA3-deficient  mouse  strain  is  not  a  perfect  tool  for 
and  that  their  retention  in  the  mast  cell  granules  depends  on  each  other. 
1996). These results suggest that CPA3 and mMCP-5 may form a complex 
the deletion of mMCP-5 caused an inability of CPA3 storage (Stevens et al. 
chymases  and  tryptases  was  noted (Feyerabend et  al. 2005).  Conversely, 
protein  level  as  well,  but  no  reduction  of  the  other  mast  cell  expressed 
classical direct knockout of CPA3 resulted in a reduction of the mMCP-5 
mouse strain has supported in depth studies of CPA3 function. However, a 
(Irani et  al. 1991; Weidner  1993). The development of a  CPA3 knockout 
in  humans  the  expression  of  CPA3 seems  to  be  restricted  to  the CTMCs
MacDonald et al. 1998; Serafin et al. 1991; Serafin et al. 1987), and also 
granules.  Murine  CTMCs  express  CPA3 (Lutzelschwab et  al. 1997;
Carboxypeptidase A3 (CPA3) is also stored in an active form in mast cell 
1.2.4 Mast cell carboxypeptidase A3
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tumour microenvironment and the tumour cell invasiveness (Komi and 
Redegeld 2019). If all these other proteases are retained in mast cell 
granules remains to be explored.  
1.2.6 Proteoglycans  
Proteoglycans (PGs) consist of a core protein attaching several highly 
negatively charged GAG chains, which pending on the cell type could be 
heparin, heparan sulphate or/and different chondroitin sulphate chains. The 
negative charge of the GAG chains will attract binding of cationic 
mediators, e.g. chemokines, cytokines, histamine and several different 
proteases. This feature also provides the strong staining properties seen in 
CTMCs when stained with cationic dyes such as toluidine blue. Mast cells 
can express several different PGs, such as syndecan, perlecan (Jung et al. 
2013; Higashi et al. 2018) and serglycin (SG). Ablation of the SG gene 
resulted in the loss of staining by cationic dyes in CTMCs, and severe 
defects in the storage of the highly positively charged mast cell proteases 
(Abrink et al. 2004). Furthermore, SG is important for the enzymatic 
activities of the mast cell proteases, where heparin attached to the SG 
protein core is essential for the mast cell chymase and tryptase activity 
(Pejler and Sadler 1999). In addition, tryptase requires heparin to stabilize 
its tetramer structure and maintain its active state (Hallgren et al. 2000; 
Hallgren et al. 2005). Thus, tryptase and chymase activity rates will be 
decreased if the GAGs on the SG core protein are degraded. In contrast, 
there is no direct evidence that the CPA3 activity is dependent on GAGs. 
However, the processing of pro-CPA3 into active CPA3 is catalysed by 
cathepsin E, which depends on heparin for correct storage (Henningsson et 
al. 2005), thus demonstrating that CPA3 enzymatic activity indirectly 
depends on the SG PG. In addition, the SG PG also influences the 
dissemination of the proteases from the secretory granule matrix when 
released at mast cell degranulation. However, mainly the tryptase mMCP-6 
and the chymase mMCP-4, but not the mMCP-7 tryptase or the mMCP-1 
chymase, have a high affinity to heparin which retain them in the close 
vicinity of the degranulated mast cell (Ghildyal et al. 1996; Schwartz et al. 
1981; Tchougounova and Pejler 2001).  
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1.2.7 Other preformed mediators 
Mast cells also produce biogenic amines such as histamine, serotonin and 
dopamine. Histamine is often used as an indicator of mast cell activation in 
the clinic. Histamine exerts its biological roles in physiological and 
pathological situations via binding to four G protein-coupled receptors, i.e. 
H1, H2, H3 and H4 (Panula et al. 2015; Seifert et al. 2013). Serotonin, 
known as 5-hydroxytryptophan, exerts its effect via binding and activation 
of seven receptors 5-HT1 through 5-HT7 (Lanfumey and Hamon 2004). 
Dopamine, derived from many cell types, is involved in the control of 
neuroendocrine secretion, cognition and locomotion mediated by binding 
to its receptors D1, D2, D3 and D4 (Jaber et al. 1996). Interestingly, the 
storage of histamine, serotonin and dopamine in mast cells relies on the 
expression of the SG PG (Ringvall et al. 2008; Ronnberg et al. 2012). 
However, the biogenic amines are not the focus of this thesis and have 
recently been reviewed extensively elsewhere (Hu and Chen 2017).  
1.2.8 Eicosanoids 
Activated mast cells (via IgE/FcεRI-receptor engagement) also release 
lipid-derived mediators, e.g. prostaglandins and leukotrienes. 
Prostaglandins are hormone-like substances involved in the control of 
blood pressure and smooth muscle contraction and regulation of gastric 
juice secretion. The prostaglandin D2 secreted by mast cells can activate 
eosinophils (Raible et al. 1992) and exacerbates food antigen-induced mast 
cell hyperplasia (Guo et al. 2010), but may attenuate anaphylactic 
reactions (Nakamura et al. 2017). Leukotriene B4 and leukotriene C4 can 
be produced by mast cells and are involved in allergic and asthmatic 
reactions. Leukotriene B4 is a chemoattractant for neutrophils and mast 
cell progenitors and recruits eosinophils during infection with Toxocara 
canis (Weller et al. 2005; Carlos et al. 2011). Leukotriene C4 secreted by 
mast cells can recruit neutrophils involved in bacterial clearance (Malaviya 
and Abraham 2000).  
1.2.9 Cytokines and chemokines. 
In a few hours after activation, intrinsically or extrinsically stimulated mast 
cells can release a vast array of different cytokines and chemokines, e.g. 
IFN-γ, TNF-α, IL-1β, IL-4, IL-5, IL-6, IL-8, IL-10, IL-33, CCL4, CCL5, 
CXCL8, CXCL10, GM-CSF, and TGF-β. Bone marrow-derived mast cells 
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release IL-1β, IL-6, IL-10, IL-13, IFN-γ, TNF-α, GM-CSF, VEGF and 
CCL8 when cultured in vitro in the presence of LPS (Palaska et al. 2016; 
Dong et al. 2019; Supajatura et al. 2002; Okumura et al. 2003). After 
stimulation with the alarmin IL-33, in vitro derived mast cells produce IL-
2, IL-5, IL-6, IL-10, IL-13, GM-CSF, TGF-β1, VEGF, CCL1, CCL2, 
CCL3, CCL17, CCL22 and CXCL8 (Morita et al. 2015; Hsu et al. 2010; 
Allakhverdi et al. 2007; Theoharides et al. 2010; Ndaw et al. 2017). 
Together, these results suggest important roles of the mast cells in 
inflammation, via secretion of cytokines and chemokines as thoroughly 
and recently discussed elsewhere (Mukai et al. 2018). 
2 Giardia 
Intestinal parasites have had millions of years to evolve regulatory 
mechanisms that circumvent the immune response, allowing for the 
longevity of the infection characteristically observed during intestinal 
parasitic infestations (King and Li 2018). Epidemiological studies have 
clearly shown that immunomodulatory products from parasites can 
interfere with and even prevent allergic inflammation, and parasitic 
infections can also affect the efficiency of vaccination (Maizels et al. 2018). 
Thus, studies aimed at exploring the mechanisms and pathways in immune 
reactions affected by the parasite immunomodulatory molecules will be 
increasingly important, for example when developing new therapeutic 
strategies.  
2.1 The protozoan parasite Giardia intestinalis 
Giardia intestinalis (also named G. lamblia or G. duodenalis) was first 
reported in 1681 by Antonie van Leeuwenhoek, known as the `the father of 
microbiology` (Dobell 1920). The parasite was named Giardia lamblia in 
1915 to commemorate the meaningful work on Giardia by professor 
Alfred M. Giard in Paris and the physician Vilem D. Lambl in Prague 
(Ford 2005). It is estimated that G. intestinalis (hereafter referred to as 
Giardia) contributes to symptomatic infections (“giardiasis”) in 200 
million people per year, mainly in Asia, Africa and Latin America per year 
(Yason and Rivera 2007). Giardiasis is characterized by gastrointestinal 
20 
 
       
 
  
 
    
     
  
  
 
 
  
 
 
 Figure 1.
infectious  lifecycle. The  general  outline  for Giardia lifecycle  is  shown  in 
months  in  moist  surroundings,  waiting  for  a  new  host  to  restart  the 
survive long in the environment while Giardia cysts can persist for many 
found  in  faeces  from  infected  individuals. Giardia trophozoites  cannot 
for  nutrient.  This  explains  why  both  cysts  and  trophozoites  forms  can  be 
trophozoites  reform  into  cysts  in  the  ileum,  most  likely  due  to  starvation 
trophozoites increases it  causes  giardiasis. Meanwhile,  some Giardia 
duodenum  and  upper  part  of  jejunum,  and  when  the  numbers  of 
by  each  quadrinuclear  cyst  continue  replication  in  the  crypts  of  the 
asexually  multiply  by  binary  fission. Four binuclear trophozoites  released 
migrate  to  the  small  intestine,  where they attach  to  the  epithelium  and 
The mature cysts survive the strong acidic environment of the stomach and 
the infection after the host has ingested contaminated food, water or drinks. 
in the host but usually the much more long lived and persistent cysts start 
life forms, the cysts and the trophozoites. Both forms can produce infection 
harsh surroundings via an environmentally-induced shifting into two main 
A  key for Giardia in  long-term  survival  is  its  strong  ability  to  adapt  to 
2.2 The life cycle of Giardia
mammals (Souza et al. 2007; Lasek-Nesselquist et al. 2010).
hoofed animals, F for cats, G for rats and H might be specific for marine 
specific,  where  C  and D  are  specific  for  dogs  and other canids,  E  for 
Nesselquist et  al. 2010).  In  contrast,  other  assemblages  are  fairly  species 
assemblages  that  infect  humans (Caccio  and  Ryan  2008;  Lasek- 
B  are  zoonotic  and  can  infect  various  species,  but  A  and  B  are  the  only 
assemblages (A to H) of Giardia have been identified. Assemblage A and 
companion  animals  and  even  in  wild  life.  To  date,  eight  well-defined 
infection cases have been reported in many kinds of livestock, sports and 
be  transmitted  between  human  and  mammals,  and  so  far symptomatic 
infection and last for two to six weeks (Pennardt et al. 2006). Giardia can 
loss. The  symptoms  usually  start  from  the  first  or  second  week after 
vomiting  and  constitutional  symptoms;  malaise,  fatigue,  anorexia,  weight 
symptoms;  abdominal  cramps,  watery  diarrhea,  epigastric  pain,  nausea, 
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Figure 1. General overview of the Giardia life cycle.1) Giardia cysts are 
ingested by the host. 2) migration to intestine. 3) one generate into four 
trophozoites. 4) replication of trophozoites. 5) attachment to epithelia cells. 6) 
encystation or not. 7) excreted with feces, trophozoites will die, cysts will wait for 
the new host. (Created with Biorender.com) 
2.3 Giardia proteins 
The detailed mechanisms explaining how the non-invasive Giardia 
parasite influences and interacts with the host are largely unknown. 
Proteins secreted by Giardia likely exert key roles during host interaction 
procedures. Several different in vitro protocols on obtaining Giardia 
protein extracts have been established.  
2.3.1 Giardia Excretory-Secretory Proteins (ESPs) 
It has been shown that Giardia secret proteins that interact with epithelial 
cells. In 1991, ESPs were obtained for the first time (Guy et al. 1991). 
Then in the following years, ESPs collected with the same procedure have 
shown several main functions,  e.g. to degrade several chemokines, 
including CXCL1, CXCL2, CXCL3, IL-8, CCL2 and CCL20 (Liu et al. 
2018); to induce local immunity via enhancement of T helper cell activity 
(Kaur et al. 1999); and to stimulate Th2 immune response leading to 
intestinal morphological changes (Jimenez et al. 2004). Several functional 
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antigens in ESPs have been identified. Indeed, it was found that some 
glycoproteins and cysteine proteases in the ESPs could induce antibody 
production in sera (Kaur et al. 2001; Jimenez et al. 2007; Jimenez et al. 
2009). Several other potentially important candidates with 
immunomodulatory capacity in the ESP fractions were also reported 
(Shant et al. 2002; Shant et al. 2004, 2005). 
2.3.2 Soluble Giardia Proteins (sGPs) 
In addition to ESPs, sGPs are used in the studies of Giardia-proteins 
inducing or modulating immune responses. sGPs can be obtained after 
simple sonication or lysis of Giardia trophozoites, and such sGPs can 
hydrolyse a variety of protein substrates, including human 
immunoglobulins (Parenti 1989). Purified sGPs fractions have selective 
antigen activities and can cause disaccharide deficiencies, as well as 
release of cytokines and activation of mast cells (Chaudhuri et al. 1997; 
Mohammed and Faubert 1995; Munoz-Cruz et al. 2018). sGPs can also 
induce production of specific antibodies and cytokines (Jimenez et al. 2014; 
Munoz-Cruz et al. 2018).  
2.3.3 Giardia-Released Proteins (GRPs) in vitro  
Unlike ESPs and sGPs that were purified from Giardia trophozoites, GRPs 
are proteins released after interaction of Giardia trophozoites with host 
intestinal/colon epithelial cell lines such as HT-29, HCT-8 and Caco-2. 
The interaction with intestinal cell lines showed that GRPs from the GS 
isolate (assemblage B) could up-regulate a wide range of genes in Caco-2 
cells, genes that are implicated in regulation of the cell cycle, apoptosis, 
inflammatory signalling and the maintenance of the mucin layer and the 
microvilli structure of the small intestine. In addition, the GRPs induced 
secretion of IL-8, CXCL1, and CCL20 in the Caco-2 cell line, and were 
found to degrade cytokines and chemokines e.g. IL-8, IL-1α, TNF-α, 
CXCL1 and CXCL3 (Ma'ayeh et al. 2018). In experiments using the HT-
29 cell line for identification of virulence factors in Giardia, proteomic 
analysis showed that around 25 secreted or membrane-associated GRPs 
were up-regulated (Emery et al. 2016). Furthermore, GRPs can induce 
caspase-dependent apoptosis as well as tight junction disruption in the 
HCT-8 cell line (Panaro et al. 2007; Koh et al. 2013). 
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Giardia proteins may play pivotal roles during the infection. A large 
number of Giardia proteins have been identified and associated with 
infection, for example Variant-Specific Surface Proteins (VSPs), surface 
antigens (SA), cyst wall proteins (CWPs), the family of cysteine proteases 
(CPs), as well as proteins in encystation specific vesicles (ESV) and in the 
endoplasmic reticulums (ERs) (Dubourg et al. 2018; Ma'ayeh et al. 2017; 
Liu et al. 2018; Rafferty and Dayer 2015; Emery et al. 2016; Hehl and 
Marti 2004). Some of these proteins have been studied in more detail: e.g. 
the Giardia enolase, a glycolytic enzyme which is involved in regulation 
of Giardia excystation (Castillo-Romero et al. 2012);  
3 Host responses in the small intestine during 
infection with Giardia intestinalis   
The small intestine can be divided into four main structural components; 1) 
the intestinal lumen, 2) the outer and inner mucus layer, 3) the epithelial 
cell barrier and 4) the lamina propria. In general, in defence against 
exogenous antigens the intestinal lumen is thought to be a biological 
barrier where the luminal microbiota to some extent can provide protection, 
e.g. via reduction of the numbers or exclusion of microbial invaders. In the 
outer and inner mucus layers mucins, secreted by goblet cells, are 
responsible for the prevention of further invasion of pathogens. The 
intestinal epithelial cells clear antigens not only by brushing them out but 
also by releasing antimicrobial factors and inflammatory mediators, e.g. 
chemokines and alarmins, that also induce the recruitment of immune cells. 
In the lamina propria sentinel cells, i.e. macrophages, mast cells and 
dendritic cells (DCs) reside, and these cells will enhance and control the 
inflammatory process.  
3.1 The intestinal epithelial cell barrier 
The intestinal epithelial cell barrier, a single layer of cells along the 
gastrointestinal tract textured into villi and crypts, consists of goblet cells, 
epithelial cells, microfold (M) cells, stem cells and Paneth cells as well as 
Tuft cells forming an innate defence barrier against exogenous toxins, 
pathogens and antigens (Bischoff et al. 2014; Groschwitz and Hogan 2009). 
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The intestinal epithelial cell barrier is primarily also implicated in selective 
absorption of nutrients and water. The tight junctions, a complex protein 
network that connects the intestinal epithelial cells and excludes foreign 
matters from accessing the body (Forster 2008; Schneeberger and Lynch 
1992), can be degraded by proteases secreted by invaders, e.g. by the 
cathepsins secreted by Giardia (Liu et al. 2018).  
Defects in the mucosal barrier and/or permeability of the epithelial layers 
are implicated in gut-associated diseases, such as irritable bowel syndrome 
and inflammatory bowel disease (Scaldaferri et al. 2012; Ohman et al. 
2015). The main function of goblet cells is to secret mucins to the outer 
and inner mucus layers, and the secretion will be increased upon infection-
induced changes. It has been indicated that secretion of mucins, in 
particular MUC2, plays a key role in the regulation of the ensuing immune 
responses in the intestine (Birchenough et al. 2015). Paneth cells also 
contribute to the barrier function through secretion of antimicrobial 
proteins (AMPs), e.g. lysozyme, cathelicidins, defensins and secretory 
phospholipase A2. AMPs can selectively disrupt the bacterial cell walls 
(Peterson and Artis 2014; Bevins and Salzman 2011; Gallo and Hooper 
2012). Studies of the intestinal epithelial cell layers revealed expression 
and secretion of IL-25 and the alarmin IL-33, two cytokines that induced a 
series of inflammatory immune responses in the early stages of microbial 
infection (Li et al. 2019; Bouchery 2019; Tahaghoghi-Hajghorbani et al. 
2019; Xiao et al. 2019).  
3.2 Giardia and the mucus layers 
When Giardia that experienced excystation migrates to the intestine from 
the stomach, mucins secreted by goblet cells will adhere to Giardia. The 
main function of mucins is to protect the mucosal epithelial cells and to 
remove invaders or harmful substances preventing them from touching the 
epithelial cell layer. Little is known about the importance of mucins during 
a Giardia infection, except that Giardia could damage the intestinal mucus 
layer through degradation of Mucin-2, leading to an increased 
translocation of bacteria (Chen et al. 2013). Interestingly, infected mucin-
2-deficient mice showed increased numbers of jejunal Giardia 
trophozoites and an impairment of weight gain as compared with wild type 
mice (Amat et al. 2017). Furthermore, Mucin-2 was reported to be 
25 
 
involved in protection against intestinal infection since the lack of the 
Mucin-2 gene contributed to exacerbated inflammatory intestinal responses 
(Hasnain et al. 2010).  
3.3 Giardia and the intestinal epithelial cell barrier 
Giardia is not an invasive protozoan parasite, so in order to take advantage 
of the bio-available nutrient they need to attach to the surface of the 
epithelium cell layer. The attachment is achieved with a suction-based 
mechanism using an adhesive disc containing around 100 proteins, e.g. 
tubulin and giardins, among other proteins (Ankarklev et al. 2010; Faubert 
2000; Woessner and Dawson 2012). Attached tropozoites synthesize and 
secrete ESPs, e.g. cysteine proteases, to disrupt intestinal epithelial cell 
tight junctions or to induce apoptosis in the epithelial cells (Ringqvist et al. 
2008; Ma'ayeh et al. 2017; Scott et al. 2002). Thus, it is speculated that 
infection with Giardia can increase the intestinal epithelial cell 
permeability, leading to a “leaky” gut. In response, epithelial cells may 
secret anti-parasitic factors such as lysozyme, which may contribute to the 
clearance of Giardia (Eckmann 2003; Tako et al. 2013).  
3.4 Giardia and interactions with immune cells in 
lamina propria 
The lamina propria located between the epithelial cell barrier and the 
connective tissue is also important for preventing the entry and spreading 
of pathogens (Wershil and Furuta 2008; Tlaskalova-Hogenova et al. 2004). 
In response to Giardia antigens immune sentinel cells in the lamina propria 
can secret several cytokines and chemokines, which will induce the 
recruitment or activation of different innate and adaptive immune cells, e.g. 
macrophages, dendritic cells, eosinophils, neutrophils, mast cells and 
several different innate and adaptive lymphoid cells.  
3.4.1 Giardia and macrophage interactions 
The macrophage, one important member of the sentinel innate immune 
cells, is associated with the killing of Giardia trophozoites. Earlier studies 
found that macrophages were effector cells and by mediating enterocyte 
damage they contributed to the removal of the Giardia infection (Kanwar 
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  product,  citrulline (Munoz-Cruz et  al. 2018),  although  the  direct
also  directly  activate mast  cells by  the  release  of  ADI  and  its  metabolic 
cells was  not  found (Munoz-Cruz et  al. 2010). In  addition, Giardia can 
TNF-α, and increase the expression of tryptase, but degranulation of mast 
Giardia-activated mast  cells were  found  to  release  histamine,  IL-6  and 
could stimulate mast cells to degranulate and to release cytokines. In vitro, 
al. 2017).  Thus  in  experimental  infection  models Giardia-induced  C3a 
C3a-desArg protein which will not cause mast cell activation (Lohman et 
infection with Giardia (Li et al. 2016). In vivo, C3a is rapidly degraded to 
recruitment  and  reduced  ex-vivo  T  cell  responses  at  resolution  of  an 
3a displayed a delayed parasite clearance, reduced mast cells sub-mucosal 
mice deficient in mannose-binding lectin or in complement receptor factor 
important for the control of the infection (Li et al. 2004). In line with this, 
delayed  elimination  of  the  infection,  suggesting  that  mast  cells  are 
et al. 2016; Li et al. 2016). Mast cell-deficient mice showed a significantly 
mast cell activation and recruitment to the small intestine in mice (Halliez 
Mast  cells  are  the  third  type  of  sentinel  cells. Giardia infection  induces 
3.4.3 Giardia and mast cell interactions
2019).
induced  IL-23  expression  in  bone  marrow  derived  DCs (Burgess et  al. 
The  authors  showed  that Giardia could  attenuate  bacterial  endotoxin 
correlation  between  malnutrition  and  the  ensuing  DC  cytokine  response. 
proliferation of T cells in vitro (Grit et al. 2014). A recent study showed a 
DCs  challenged  with Giardia trophozoites or  ESPs  increased  the 
lymph nodes where they activate naïve T-cells (Lopez-Romero et al. 2015).  
recognize  and  endocytose Giardia antigens,  before  migrating  to  draining 
propria DCs with elongated dendrites to increase efficient surveillance will 
Dendritic cells (DCs) are also considered to be sentinel cells. In the lamina 
3.4.2 Giardia and dendritic cell interactions
oxide synthase inhibitor (Fernandes and Assreuy 1997).
Furthermore, the killing rate of macrophages could be inhibited by a nitric 
and  Pohl  1990;  Kaplan et  al. 1985;  Belosevic  and  Daniels  1992). 
IFN-γ  in  response  to  the Giardia challenge (Hill  and  Pearson  1987;  Hill 
macrophages  could  ingest Giardia trophozoites  and  release  TNF-α  and 
et  al. 1987;  Goyal et  al. 1993). In  vitro experiments  showed  that 
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interaction of Giardia-derived molecules does not seem to cause mast cell 
degranulation (Munoz-Cruz et al. 2018; Munoz-Cruz et al. 2010).  
3.4.4 Giardia and neutrophil interactions 
Recruited neutrophils also seem to play key roles during the Giardia 
infection. However, the specific roles of neutrophils remain poorly 
understood. Two neutrophil defensins HNP-1 and NP-2 were found to 
reduce the viability of Giardia trophozoites (Aley et al. 1994), and the 
adherence of Giardia to the epithelial cell layer could be inhibited by two 
neutrophil derived enzymes, lysozyme and β-glucuronidase (Crouch et al. 
1991). Another interesting finding is that Giardia trophozoites adhered 
poorly to neutrophils when heat inactivated complement components or 
monoclonal antibodies directed towards low affinity Fc receptors were 
used (Arbo et al. 2006). Furthermore, although neutrophil infiltration was 
reported to be increased in human patients and in BABL/C mice infected 
with Giardia (Abbas et al. 1994; Chen et al. 2013), the number of MPO 
positive neutrophils in infected C57BL/6 mice was found to be similar to 
the uninfected control mice (Cotton. et al. 2014). This suggests that 
Giardia potentially could block neutrophil activity in vivo. In line with this 
it was found that Giardia ESPs such as cathepsin B efficiently degraded 
the chemokine IL-8/CXCL8 and thus could attenuate neutrophil 
recruitment (Cotton. et al. 2014; Cotton et al. 2014).  
3.4.5 Giardia and interactions with T and B cells  
T cells are reported to play pivotal roles in the immune response to Giardia 
infections. T-cell-deficient mice failed clearance of Giardia (Singer and 
Nash 2000). Ex vivo experiments showed that challenge with Giardia 
induced the proliferation and/or activation of lymphocytes or blood CD4-
positive (CD4+) and/or CD8+ T cells (Ebert 1999; Gottstein et al. 1991; 
Hanevik et al. 2011; Hanevik et al. 2012). The activation of T cells 
through complement factor 3a is important for Giardia control (Li et al. 
2016) and helper T cells but not cytotoxic T cells were reported to be 
required for elimination of Giardia (Heyworth et al. 1987; Ermak et al. 
1988; Khanna et al. 1990; Vinayak et al. 1989). Furthermore, Giardia-
stimulated bovine monocyte-derived DCs induced the proliferation of 
CD3-negative γδ-T-cells, and CD4+ and CD8+ TCRαβ+ T-cells (Grit et al. 
2014). Interestingly, Giardia antigens in the molecular weight range of 90-
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110, 65-77 and 40-64 kDa were shown to activate T cells (Astiazaran-
Garcia et al. 2009). 
In addition, B cells may also play a significant role in the host defence 
against infection with Giardia. The number of B cells was increased in 
mice with orally administrated Giardia (Lee et al. 2009). However, as 
compared with T-cell-deficient mice, which completely failed to clear 
Giardia, B-cell-deficient mice showed a capacity to control Giardia 
(Singer and Nash 2000; Langford et al. 2002).   
3.4.6 Giardia and regulation of cytokines / chemokines 
The important roles of cytokines and chemokines during infection with 
Giardia cannot be ignored (reviewed in detail (Lopez-Romero et al. 2015)). 
Giardia causes a mixture of Th1/Th2/Th17 immune responses and the 
importance of several cytokines in giardiasis was addressed using IL-17A 
Receptor-deficient mice as well as IL-6, IL-9 or TNF-α -deficient mice, 
which all were found to display a delayed clearance of the Giardia 
infection (Li et al. 2004; Zhou et al. 2007; Dann et al. 2015). Cytokines 
and chemokines that display altered expression levels during giardiasis in 
different models are summarized in Table 2. 
Table 2. Cytokines and chemokines involved in Giardia infection.   
Cytokines and  
Chemokines 
Induction 
by Giardia 
Model materials References 
TNF, IFN-γ, IL-1β, IL-4,  
IL-5, IL-6, IL-10, IL-17  
Up regulated Gerbils (Serradell et al. 2018) 
IL-8, IL-1α, TNF-α, 
CXCL1, CXCL2, CXCL3, 
CCL20 
Degraded Caco-2 intestinal 
epithelial cells 
(Liu et al. 2018) 
TNF-α, IL-12,   
IL-6, IL-2, IFN-γ 
Increased TLR2
-/-
, TLR4
-/-
 
mice, DCs 
(Lee et al. 2014) 
IL-4, IL-5, IL-10 Increased Spleen cells and 
intestinal fluids 
(Jimenez et al. 2014) 
IL-8 Increased Caco-2 intestinal 
epithelial cells 
(Fisher et al. 2013) 
IL-4 Up regulated IL-6-deficient mice (Bienz et al. 2003) 
CCL2, CCL20, CXCL1, 
CXCL2, CXCL3 
Up regulated Caco-2 intestinal 
epithelial cells 
(Roxstrom-Lindquist et 
al. 2005) 
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4 Hypothesis and aims 
 
The hypothesis of this thesis was that the mast cell-specific proteases 
chymase and tryptase expressed by connective tissue mast cells could 
affect the intestinal immune responses towards infection with the non-
invasive protozoan parasite Giardia intestinalis. 
The aims were to investigate and characterize potential interactions 
between the connective tissue mast cell-specific proteases and secreted 
Giardia proteins, and to characterize the intestinal immune responses to 
infections with G. intestinalis in knockout mouse models, lacking the 
chymase mouse mast cell protease-4 or the serglycin proteoglycan. 
The specific objectives were to: 
 Establish in vitro mast cell culture models for studies of the 
interactions with G. intestinalis.  
 Establish an in vivo gavage-infection model in the mMCP-4 and 
the SG proteoglycan knockout mouse models 
 Analyze the immune responses to the G. intestinalis infection in 
the knockout mouse models  
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subjected to sorting by anion-exchange and size-exclusion chromatography
potential  fractions  of  sGPs  that  influenced  on  the  tryptase  activity  were 
activities  of  the  human  and  the  mouse  mast  cell  specific  proteases.  The 
3).  Furthermore,  I  studied  if  sGPs or ESPs  could  affect  the enzymatic 
chymase  were  sent  for proteomics to identify  the Giardia proteins  (Table 
or chymase could degrade any of the sGPs. The protein bands degraded by 
activation status of the mast cells. I also investigated if mast cell tryptase 
CTMCs  and  MMCs  with  soluble Giardia proteins  (sGPs)  to  evaluate  the 
in  IL-3,  SCF,  TGF- and  IL-9  conditioned  media.  I  then  challenged  the 
derived in IL-3 and stem cell factor (SCF) conditioned media and MMCs 
according  to  two  slightly  different  cell  culture  protocols.  CTMCs  were 
the  outcome  of  such  interactions  I  cultured  mouse  bone  marrow  cells 
as  the  mast  cell  specific  proteases  and Giardia proteins  exist.  To  address 
Here I investigated if potential interactions between the mast cells as well 
proteases and Giardia proteins
5.1 In vitro experiments: interactions of mast cell
Giardia proteins.
the   villi   and   potentially   makes   an   interaction   with   the   infiltrating 
after activation of the crypt-dwelling CTMCs the chymase can diffuse into 
small intestine will secrete immunomodulatory proteins into the villi, and 
envisage.  However,  the trophozoites  attached to  the  epithelial  cells  in the 
which is not invasive, a direct interaction with the chymase may be hard to 
immune  response  can  be addressed.  During  infection  with G. intestinalis, 
models,  compared  with cell  cultures, are that the  concerted  actions of  the 
strains deficient for mMCP-4 or SG. The advantages with mouse knockout 
during infection with G. intestinalis I have used genetically targeted mouse 
the  functions  of  the  mast  cell-specific  chymase  as  well  as the  serglycin 
address the impact of G. intestinalis on intestinal mast cells. To elucidate 
In this thesis I have used both in vitro and in vivo experimental models to 
5 Present investigations
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(Figure 2). Proteomics were performed to identify the proteins in the 
fractions that affected the tryptase activity (Table 4). 
Table 3. Top 10 Giardia proteins probably degraded by rCh 
Accession Description MW[kDa] calc. pI 
V6U7H9 Phosphoglucomutase /Phosphomannomutase  73,5 5,50 
A0A132NU12 Putative Alanine aminotransferase  58,4 7,68 
V6U395 Arginine deiminase  64,3 6,54 
Q24967 Immunoglobulin heavy chain binding protein 72,6 5,10 
C6LZK0 Malic enzyme  61,3 7,20 
V6TS77 Tenascin family protein 61,2 4,67 
C6LR45 Tenascin-like protein 64,7 4,59 
V6U3S0 High cysteine membrane EGF-like protein 62,0 5,10 
V6TT28 Variant-specific surface protein  73,1 5,41 
V6TZJ9 EGF-like cyst protein  63,2 4,37 
 
Table 4. Top 5 proteins in each band possibly enhancing mast cell tryptase activity 
Protein 
bands 
Accession Description MW [kDa] calc. pI 
Upper C6LRY8 UPL-1 34,4 7,30 
 V6U387 Thioredoxin reductase 33,9 6,61 
 V6TU22 Serine/threonine-protein phosphatase 35,5 5,45 
 C6LPK2 Ornithine carbamoyl transferase 36,5 7,03 
 V6U471 Cathepsin B-like cysteine proteinase 35,2 5,52 
Middle V6TSI5 Alpha1-giardin  33,8 6,73 
 V6U387 Thioredoxin reductase  33,9 6,61 
 Q2QBT8 14-3-3 protein  28,6 5,17 
 V6TX12 Cathepsin B-like cysteine proteinase 32,8 5,12 
 A0A132NVX4 Uncharacterized protein 30,0 4,53 
Lower Q2QBT8 14-3-3 protein 28,6 5,17 
 A0A1L7B7I7 Beta-giardin  23,2 5,16 
 Q01832 Protein C4  22,3 8,54 
 C6LQF2 Eukaryotic translation initiation factor 6 26,7 5,55 
 V6U362 Proteasome endopeptidase complex  27,5 5,29 
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Figure 2. The outline for the in vitro Giardia mast cell protease interaction experiments.  After establishing the impact of Giardia 
sGPs on the tryptase activity, the sGPs was further purified and fractionated by anion-exchange and size-exclusion chromatography. The 
effect of eluted fractions on recombinant human tryptase (rHT) was determined then the proteins having a positive influence on the rHT 
activity were visualized on gel. (Created with biorender.com) 
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5.2 In vivo experiments: mast cell protease-deficient 
mice and infection with Giardia 
5.2.1 Kit dependent mast cell deficient mice 
To date, naturally occurring mutations of the mice that selectively delete 
only mast cells have not been found. Kit tyrosine kinase, encoded by the c-
kit gene, is the receptor for stem cell factor (SCF) that regulates the 
maturation, survival, proliferation and functional responses of mast 
cells (Galli et al. 2015). C-kit is highly expressed not only in mast cells but 
also in other cell types such as hematopoietic stem cells and immune 
cells. Thus, mice carrying mutations in the c-kit gene usually show mast 
cell deficiency as well as other cell type abnormalities (Galli et al. 2015). 
The two mouse strains Kit
W/W-v 
and Kit
W-sh/W-sh 
have commonly been used 
for the analysis of potential functions of mast cells in vivo. Compared with 
the Kit
W/W-v
 mouse strain, the Kit
W-sh/W-sh
 mouse strain has fewer 
abnormalities with relatively increased numbers of neutrophils and 
basophils, and is neither sterile nor anemic (Galli et al. 2015). The Kit
W/W-v 
mouse strain has been used to claim that mast cells are important for 
protection against and elimination of the Giardia-infection (Li et al. 2004). 
In addition, it was shown that c-kit depleted mice, i.e. mast cell deficient, 
showed similarly increased numbers of parasites as the Kit
W/W-v
 mice (Li et 
al. 2004). However, to date there are no reports on that Kit
W-sh/W-sh
 mice 
was used for the study of mast cells in Giardia infection in vivo. I therefore 
used the Kit
W-sh/W-sh
 mice to establish the Giardia infection mouse model 
and to evaluate if this mouse strain had the same response profile as the 
Kit
W/W-v
 mouse strain. In the vast majority of the Giardia-infection studies, 
to date, the authors have used mice in the age range of 3 to 10 weeks. 
These young mice are in their growing phase and will usually gain weight 
even when they are infected with G. intestinalis. The outcome of the 
infection in older full-grown (mature adult) mice is much less studied. 
Therefore, I used aged/mature adults (22-36 weeks old) Kit
W-sh/W-sh 
mice to 
address the response to G. intestinalis in adult mice lacking mast cells. 
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5.2.2 The mouse Mast Cell Protease-4-deficient and the Serglycin-
deficient mouse strains 
The mMCP-4 and the SG-deficient mouse strains were conceived, 
constructed and produced in Uppsala. The targeted deletion of both 
mMCP-4 and SG involved the replacement of exon 1 with a Neomycin-
cassette, which however was not floxed. Thus, the resulting targeted mouse 
strains carry the Neomycin-cassette and if the Neomcyin-promotor 
produces any off-target effects the best control of the homozygote deficient 
mice may in fact be the heterozygote mice.  
Initial characterization of the mMCP-4-deficient mouse strain showed 
similar levels of mMCP-4 protein in the mMCP-4
+/+
 and mMCP-4
+/- 
mice, 
and that the deletion of the mMCP-4 protein did not affect the numbers of 
mast cells or the expression of the other connective tissue mast cell-
specific proteases in the mMCP-4
-/-
 mice (Tchougounova et al. 2003).  
The deletion of SG resulted in multiple changes in the storage of cationic 
mediators, e.g. storage of histamine and serotonin, and the proteases 
mMCP-4, mMCP-5, mMCP-6 and CPA in mast cells (Abrink et al. 2004). 
However, when assessing the expression of neighboring genes in the SG
+/-
 
and SG
-/- 
mice no major differences was found (Roy et al. 2016), 
suggesting that the SG
+/- 
mice is as valid as the SG
+/+
 mice as
 
a control for 
the SG-deficiency.  
The mouse strains referred to above, i.e. Kit
W-sh/W-sh
, mMCP-4, or SG on the 
C57BL/6J Taconic genetic background (backcrossed for more than 20 
generations) were used to establish the Giardia intestinalis trophozoite 
gavage-infection mouse models. Clinical scoring in the mMCP-4-deficient 
and the SG-deficient mice was performed in a blinded fashion, i.e. the 
genotypes were not known to the assessor. Since infection with G. 
intestinalis potentially could cause weight loss or reduced weight gain, 
weight data were recorded before infection (day 0) and then every second 
or third day. From infected and control mice feces, tail tissue, serum, and 
intestines (jejunum and duodenum) were collected (Figure 3). 
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.  
Figure 3. The procedures of in vivo Giardia infections and the sampling of 
tissues.  10
6
 Giardia trophozoites were administered to the different knockout 
mouse strains by oral gavage. Weight data and fecal samples were collected every 
two or three days post infection. At the experimental endpoint, serum and 
intestines were sampled for each mouse. (Created with biorender.com) 
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6 Results and discussion 
Supplementary results are shown here to support Paper I-III 
6.1 Giardia excretory-secretory proteins modulate 
the enzymatic activities of mast cell chymase 
and tryptase (Paper I) 
6.1.1 The interaction of soluble Giardia proteins (sGPs) with mast 
cells 
Previous studies have shown that sGPs can activate rat mucosal-like mast 
cell lines (Munoz-Cruz et al. 2010; Munoz-Cruz et al. 2018). In Paper I 
mouse bone marrow-derived connective tissue mast cells (CTMCs) and 
mucosal-like mast cells (MMCs) were challenged with sGPs to study the 
activation of MMCs. Interestingly, no clear activation of the CTMCs 
(Figure 4) occurred whereas sGPs from the three different isolates (GS, 
WB, H3) caused very similar activation of the MMC, with increased IL-6 
production and tryptase activity. However, the activation induced by sGPs 
was very minor and, probably sGPs did not cause degranulation of the 
MMCs since no change of the activity of the granule-stored mast cell-
activation marker β-hexosaminidase was found in the collected 
supernatants.  
6.1.2 The interaction of soluble Giardia proteins (sGPs) with mast 
cell proteases 
To study if any of the sGPs were degraded by mast cell proteases, 
recombinant human tryptase (rHT), recombinant human chymase (rCh) or 
by wild-type mouse ear tissue proteolytic extracts were used. Strikingly, 
sGPs were not extensively degraded by the recombinant human proteases 
or by the ear tissue mouse mast cell proteases. This was unexpected since 
such degradation has previously been observed in protein extracts derived 
from the protozoan Toxoplasma gondii, and the parasitic worms 
Heligosomoides polygyrus and Trichinella spiralis (Roy et al. 2016). 
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Figure 4. IL-6 level and tryptase activity in connective tissue mast cell 
supernatants after challenge with soluble Giardia proteins. 1x10
6
/ml BMMCs 
were incubated without or with sGPs (ranging from 25ng/ml to a 100µg/ml in 
concentration), then supernatant was collected at time point 6h and 24h after cells 
were stimulated to be used for measurement of (a) IL-6 and  (b) tryptase 
activity(difference of optical density (OD) between 3h and 0h was calculated).   
 
  
a 
b 
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Figure 5. Optimization of working concentration of rHT and the effect of 
NaCl-concentration on rHT and rCh. a) Different amounts of rHT in 10 μl PBS 
reacted with 20μl of the substrate S-2288 + 90µl PBS. b) The optimal activity of 
0.01μg rHT for the substrate S-2288 in different PBS+ NaCl-concentrations. c) 
The optimal activity of 0.05μg rCh for the substrate L-1595 in different PBS+ 
NaCl-concentrations. In (a, b, c) changes in the absorbance was measured at 
405nm every 10 minutes, 30 minutes or 1 hour, respectively, for 2, 4 and 5 hours. 
a 
b 
c 
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To further study potentially functional interactions between the mast cell 
specific proteases and Giardia proteins, the concentrations of rHT, as well 
as the salt concentration (NaCl) previously shown to affect the proteolytic 
activities of tryptase and chymase were optimized (Figure 5). In the 
absence of heparin high NaCl-concentrations maintain the stability of the 
tryptase tetramer, however, the tryptase tetramer will decay into monomers 
if stored long term in high NaCl concentrations also slow down the activity rate 
of tryptase (Pereira et al. 1998; Hallgren 2001). Optimal conditions for the 
enzyme reactions were determined to be: PBS containing 0.15M NaCl; 
0.01µg of the recombinant human tryptase and 0.05µg of the recombinant 
human chymase. These conditions were used in the further interaction 
studies using Giardia-derived soluble proteins (sGPs) or excretory-
secretory proteins (ESPs). Surprisingly, an enhancing effect of both sGPs 
and ESPs on the activity of rHT and mouse ear tissue extracts was 
observed for the chromogenic substrate S-2288. In contrast, sGPs were 
found to significantly inhibit the rCh activity and the WT mouse ear tissue 
extract activity for the substrate L-1595. These results suggest that sGPs 
and ESPs potentially can modulate mast cell protease activities in vivo and 
thus may affect mast cell driven immune responses. 
6.1.3 Sorting out the interacting proteins 
Two chromatography methods were used in the following attempts to sort 
out and identify the sGPs that affected the tryptase activity. Using anion-
exchange chromatography fractions of sGPs were eluted by increasing 
concentrations of NaCl, step vise from 0.15 M to 2.0 M NaCl. The second 
fraction eluted with 0.5 M NaCl significantly enhanced the rHT activity 
and the SDS-PAGE gel electrophoresis showed proteins in this fraction 
with molecular weights ranging from 10 to 35 kDa (Figure 6). A second 
independent experiment repeating the anion-exchange fractional 
purification of the GS, H3 and WB Giardia-isolate proteins gave very 
similar results as those presented in Figure 6. The Giardia-proteins were 
also fractionated with size-exclusion chromatography. Interestingly, the 
size-exclusion fractions numbered 26, 29, 32, 33, 34, 35, 36, 37, and 38 
showed significant enhancement of the rHT activity (Figure 7).  
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Figure 6. Anion-exchange fractions eluted at 0.5M NaCl enhances the activity 
of rHT. 400µg of sGPs in PBS from the GS, WB and H3 Giardia isolates were 
loaded onto a 0,5 ml DEAE Sephacel
TM
 column (GE Healthcare) and the bound 
sGPs were stepwise eluted twice by 0.15M, 0.5M, 1M and 2M NaCl in PBS. a) 
The eluted fractions were then incubated with 0.2μg rHT (old batch) + the 
chromogenic substrate S-2288, and optical density (OD) was measured every 5 
minutes up to 30 minutes, and all OD values were normalized to the OD value at 0 
minute. b) The different fractions of sGPs were checked by SDS-PAGE gel 
electrophoresis. The protein bands in the red frame were cut out from the gel and 
identified by proteomics. In panel a & b representative results of the GS Giardia 
isolate fractions is presented. Very similar (identical) results were obtained with 
the H3 and WB Giardia isolates (data not shown). 
 
a 
b 
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Figure 7.  Fractions enhancing activity of rHT. 1mg of GS sGPs were eluted in 
a size-exclusion chromatography HPLC-system. a) Each fraction with detectable 
protein levels was then tested for enhancement of the rHT activity. Protein 
fractions were then incubated with 0.2μg rHT (old batch) + the chromogenic 
substrate S-2288, and optical density (OD) was measured every 5 minutes up to 30 
minutes, and all OD values were normalized to the OD value at 0 minute. b) The 
fractions containing proteins and with an enhancement effect were checked by 
SDS-PAGE gel electrophoresis. 
  
a 
b 
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The visualization of proteins in these fractions indicated that the molecular 
weight of interesting proteins was in the range of 15 to 35 kDa. Attempts 
were therefore made to identify the 15-35 kDa Giardia-proteins (red frame, 
with three major protein bands) in Figure 6 using a proteomics approach. 
The top 5 proteins of each band, with a molecular weight of 20-35 kDa, are 
shown in Table 4. In addition, the 65 kDa protein band in the sGPs that 
potentially could be degraded by rCh was sent for proteomic identification. 
The top 10 candidate proteins in the 65kDa band are shown in Table 3. 
Some of these candidate proteins shown in Tables 3 and 4 have been 
reported to be important in Giardia. It was found that thioredoxin 
reductase of Giardia could catalyse the reduction of drug (metronidazole 
and furazolidone) (Leitsch et al. 2016). The serine/threonine-protein 
phosphatase was shown to be involved in Giardia differentiation, where it 
was upregulated in the early stage of excystation (Lauwaet et al. 2007). 
Ornithine carbamoyl transferase catalyze citrulline to produce ATP 
(Galkin et al. 2009). Giardia cathepsin B which is important for Giardia´s 
encystation and excystation (DuBois et al. 2008) can degrade epithelial 
cell tight junction proteins and chemokines (Cotton et al. 2014; Liu et al. 
2018). Alpha1-giardin, a structural protein of Giardia trophozoite, was 
shown to be a potential vaccine antigen candidate in a murine model 
(Jenikova et al. 2011). The 14-3-3 protein involved in Giardia 
differentiation opens up for anti-giardia drug design (Fiorillo et al. 2014). 
Beta-giardin gene detection by nested PCR is constantly used for 
identification of Giardia in most infected animal species and humans 
worldwide, but the functional role of beta-giardin is still unclear. 
Phosphoglucomutase can be utilized by Giardia to isomerase glucose-6-
phosphate to glucose-1-phosphate to make glycophosphosphoinositol 
anchors (Mitra et al. 2010). The arginine deiminase (ADI), a metabolic 
enzyme secreted by Giardia can consume arginine causing the reduction of 
epithelial cell proliferation (Stadelmann et al. 2012), and ADI induces 
MMCs to release significant levels of IL-6 and TNF-α (Munoz-Cruz et al. 
2018). Tenascin was suggested to be implicated in the regulation of 
Giardia trophozoite attachment (Emery et al. 2016). Epidermal growth 
factor-like protein may be also involved in Giardia encystation (Chiu et al. 
2010). Variant-specific surface proteins could induce strong antibody 
responses (Serradell et al. 2018). In addition, there are additional secreted 
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Giardia proteins shown to have immunogenic capacity, as reviewed in 
(Lopez-Romero et al. 2015).  
Considering the functions of these proteins, it would be interesting to know 
which of the Giardia protein(s) that influences on the tryptase and 
chymase enzyme activities. This would further increase the knowledge on 
how mast cell proteases interact with Giardia.  
6.2 Experimental Giardia infection in c-kit dependent 
mast cell deficient mice causes increased weight 
loss  
To increase the infection rate it has been common to use antibiotic pre-
treatment of the mice during experimental infections with Giardia 
trophozoites from human isolates. However, pre-treatment with antibiotics 
will reduce the microbial load of the intestine and produces a very artificial 
milieu for the studies of Giardia and the ensuing host immune reactions. 
Thus, to avoid this we established a gavage model without antibiotic pre-
treatment of the mice to be used for our studies of the mast cell specific 
proteases. Furthermore, most studies used young mice (≈6-8 weeks old) or 
very young mice (≈3-6 weeks old) to investigate potential weight changes 
and immune regulatory mechanisms. Therefore, mature adult mice 
(i.e. >18 weeks old mice) which have reached a plateau in their weight 
gain were included to study potential age-related weight losses and 
immune regulatory mechanisms.  
The gavage model was initially evaluated with mature adult congenic 
Kit
+/+
 and Kit
-/-
 littermate mice infected with the Giardia GS isolate 
(Figure 8a and b), where we scored weight changes every second day up to 
day 18. From day 8 and onwards the weight change in relation to the day 
of infection differed significantly between the two groups, indicating that 
the c-kit dependent mast cell-deficient mice were more vulnerable to the 
infection. Thus, an experimental Giardia-infection model, without 
antibiotic treatment of the mice and suitable for mast cell studies was 
established and applied in the subsequent studies. 
 
44 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 8. Giardia intestinalis infections in c-kit dependent mast cell deficient 
mice without antibiotic treatment. Successful establishment of the infection 
model in age grouped wild-type congenic Kit
+/+
 and Kit
-/-
 (Kit
W-sh/W-sh
) littermate 
mice. Mice were infected by gavage with ≈106Giardia intestinalis trophozoites. 
Weight data (in gram) and feces were collected every second day before the mice 
were euthanized day 18. a) Weight changes in-between days in 22-36 weeks old 
Kit
+/+
 (n=5) and Kit
-/-
 (n=5) mice during infection with the Giardia. A statistical 
analysis weight changes between D4-D6, D6-D8, as well as D8-D10 is shown. * 
indicate a significant p value between Kit
+/+ 
and Kit
-/- 
mice. # indicate significant 
changes in infected Kit
+/+
 mice between day 8 and day 10, § indicate changes in 
infected Kit
-/-
 mice between day 6 and day 8, (#, §, *) p value <0.05. (b) Weight 
changes relative to initial weight at day 0 was determined. * indicate a significant 
p value <0.05 between Kit
+/+
 and Kit
-/-
 mice.  
 
a 
b 
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6.3 The chymase mouse mast cell protease-4 
regulates intestinal cytokine responses in mature 
adult mice infected with Giardia intestinalis 
(Paper II) 
The role of mMCP-4 at infection with Giardia intestinalis was studied 
using the chymase mMCP-4-knockout mouse strain. Littermate mMCP-4
-/-
 
and mMCP-4
+/+
 mice were infected with 10
6 
Giardia trophozoites by oral 
gavage and uninfected littermates were used as un-treated controls. The 
infection was followed for 8 or 13 days by recording clinical signs, weight 
data and collection of feces. Genotypes of the infected mice were 
determined after the experimental endpoint. At endpoint, serum samples 
and samples from the small intestine were collected. The intestinal samples 
were further divided into smaller pieces, for RNA extraction and 
subsequent PCR-analysis, for morphological studies, for DNA extraction 
and for extraction of proteins and subsequent biochemical analysis 
including enzymatic assays.  
6.3.1 Weight loss in Giardia-infected mature adult mice 
Feces and intestinal DNA samples were subjected to a nested PCR to 
detect Giardia DNA. Successful infection was shown in all gavage-
infected mice. Importantly, uninfected control mice did not catch the 
infection during the experimental period. Since IL-6 can affect the 
outcome of  giardiasis, the serum levels of IL-6 were measured and found 
to be increased in infected mMCP-4
-/- 
and mMCP-4
+/+
 mice as compared to 
control mice, further supporting a successful infection in all mice as 
confirmed by the nested PCR. Recent reports show that Giardia is a 
significant factor in the induction of reduced weight gain and stunting of 
young children in low-resource settings (Donowitz et al. 2016; Rogawski 
et al. 2018). In paper II I found that infected mice showed significant 
weight loss compared to uninfected mice. Interestingly, between day 2 and 
day 4 post infection an increased weight loss in mMCP-4
-/-
 mice was 
observed, as compared with mMCP-4
+/+
 mice, a difference between 
genotypes that was lost at endpoint, day 8 or day 13. According to the 
weight data, it would be interesting to study the intestinal infection status 
or immune responses caused by Giardia at day 2 or 4 in infected mice. 
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However, the current experimental design focused on day 8 as this has 
been reported as the peak infection day for Giardia in mice.   
6.3.2 Significantly decreased neutrophil elastase (NE) activity in 
Giardia- infected mice  
The morphological assessment of the small intestines at day 8 showed no 
or very minor differences between mMCP-4
-/-
 and mMCP-4
+/+
 mice. 
Compared with uninfected mice the Giardia-infection caused a similarly 
increased goblet cell counts and a minor increase in granulocyte counts in 
both genotypes. However, the increase in granulocyte counts were not 
reflected by increased myeloperoxidase or neutrophil elastase (NE) activity. 
In contrast, the Giardia infection caused a significantly decreased 
intestinal NE activity, an observation that was confirmed in vitro, using 
soluble Giardia proteins and recombinant human NE. Thus, Giardia seems 
capable to inhibit the two proteases NE and chymase (see paper I) 
expressed by two different innate immunity cell types, i.e. neutrophils and 
mast cells.  
6.3.3 The mMCP-4 regulates intestinal cytokines and chemokines 
in mature adult mice infected with Giardia intestinalis 
To address what innate and adaptive immune responses Giardia can cause 
in the absence of mMCP-4 in mice the transcriptional expression profile of 
intestinal cytokines and chemokines was determined by qPCR. On the 
whole, the intestinal immune response to Giardia was more pronounced on 
day 8 than day 13 post infection. An extensive screening for expression of 
cytokines and chemokines in the small intestines of the control and 
infected mice showed an overall increase of the expression levels in 
infected mice. Strikingly, lack of the chymase mMCP-4 caused a 
significantly reduced upregulation of the expression of IL-6, TNF-CCL2, 
CXCL2, IL-2, IL-5, IL-17a, IL-17c and IL-10. In addition, IL-4 was 
significantly downregulated in the chymase-deficient mice. The onset and 
the chymase-dependent regulation of IL-25 and IL-33 in infected mice is a 
new finding, and suggests that chymase is involved in the early onset and 
recruitment of innate lymphoid cells. Furthermore, the reduced cytokine 
expression in mice lacking mMCP-4 suggests that chymase is involved in 
the regulation of inflammatory cytokine response profiles. If this 
regulation is direct or indirect remain to be determined. 
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In previous studies research groups most often used 5 to 10 weeks old mice 
for their experimental infections with G. intestinalis. The mature adult 
mice (>18 weeks old) that I have used is one of the first studies, to my 
knowledge, that experimentally address the effect of age of mice during a 
Giardia-infection. The level of cytokines and chemokines can be affected 
by age or sex during parasite infections (Lechner et al. 2013; Roberts et al. 
2001). For example, an ex vivo experiment showed that the expression 
levels of chemokines and cytokines in peripheral blood mononuclear cells 
and umbilical cord blood cells sampled from neonates, children, adults, 
and the elderly were pronouncedly different (Lechner et al. 2013). In 
addition, it was found that the immune cells that expressed specific sex 
hormone receptors, for example for progesterone or estrogen, when 
challenged with LPS responded by reduced production of cytokines 
(Roberts et al. 2001). To reduce the influence of age variation the mice 
selected for qPCR analysis were around 20 weeks old. In addition, since 
the trends of weight loss of the mature adult females and males were found 
to be similar post Giardia-infection, the data obtained from females and 
males, e.g. in the qPCR, were pooled for the respective genotypes. Instead 
I focused on the potential differences in cytokine expression at day 8, i.e. 
peak day of infection, versus day 13 when elimination of the infection 
should have been initiated.   
6.4 The mouse serglycin proteoglycan regulates 
immune responses in a sex-specific direction 
during infection with Giardia intestinalis (paper III) 
Many of the preformed mast cell specific mediators, e.g. mMCP-4, 
mMCP-6 and CPA3, rely on the serglycin (SG) proteoglycan for correct 
storage and function. The SG-knockout mouse strain was therefore used to 
address the combinatorial effects of multiple protease deficiency upon 
combating a Giardia-infection.  
Infection procedures and sampling of the mice were performed as 
described in Paper II. In brief, 7 to12 weeks old serglycin-deficient (SG
-/-
) 
and serglycin-competent (SG
+/+
) littermate mice were infected by oral 
gavage with 10
6
 Giardia trophozoites. PBS-challenged littermate mice of 
similar ages were used as controls. Infection was followed for 12 days, 
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where clinical and weight data scoring, and collection of feces from 
infected mice was performed. Genotypes of the infected mice were 
determined after the experimental endpoint. At endpoint serum and the 
small intestine of all mice were sampled. The small intestines were 
collected and divided separately for RNA and protein extraction, and for 
studies of morphological changes. 
6.4.1 Reduced weight gain in Giardia-infected mice 
Successful infection was shown in all gavage-infected mice by a nested 
PCR detection for Giardia in fecal samples and increased IL-6 levels in 
serum. Compared with PBS-gavage control mice, infection with Giardia 
caused a reduced weight gain before 7 days post infection (dpi). In addition, 
the infected SG
-/-
 mice showed a delayed and reduced weight gain starting 
from 5 dpi as compared to the infected SG
+/+
 mice. Interestingly, when the 
weight data were sorted by sex, infected females showed more obvious 
reduction of weight gain. According to the weight data, it would be 
attractive to also determine the intestinal infection status and the resulting 
immune responses at early days, especially day 5, in the infected mice. 
However, in the current experimental design I focused on day 12 as this 
has been commonly used for the study of Giardia in mice.   
6.4.2 Increased goblet cells as well as granulocytes counts and 
decreased neutrophil elastase activity 
The clinical scoring of mice showed only very mild symptoms, with mice 
producing “softer” feces around three dpi. Morphological assessment of 
the small intestines at 12 dpi showed higher numbers of goblet cells and 
granulocytes in mice infected with Giardia in comparison to the control 
mice, with  only minor differences between SG
-/-
 and SG
+/+
 infected mice. 
The neutrophil elastase (NE) activity in the intestinal tissue was 
significantly inhibited in infected mice (a similar finding to what I show in 
Paper II), with no difference between the SG
+/+
 and SG
-/- 
mice.  
Collectively, these results suggest that the NE activity is not SG-dependent 
during infection and that Giardia may cause the reduction of the NE 
activity observed.  
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6.4.3 The intestinal cytokines and chemokines regulated by SG in 
mice infected with Giardia intestinalis is sex dependent 
To address what impact SG could have on the immune responses during 
experimental infection with G. intestinalis I evaluated the intestinal 
cytokine and chemokine expression levels by qPCR. According to the 
weight data, the reduced weight loss of infected young mice was mainly 
contributed to by the female mice. Therefore, I sorted the mice into sex 
groups. Interestingly, only minor differences of detected gene expressions 
between infected SG
+/+
 and SG
-/- 
mice was found. The lack of SG in female 
mice resulted in a significant reduction of CXCL2 and IL-6, and a trend 
towards downregulation of IL-25, IL-33, TNF-α and NOS2, as well as a 
trend towards upregulation of CXCL1 and IFN-γ. In male mice lacking SG 
a significant upregulation of NOS1, IL-2, IL-4, IL-5, and a trend towards 
upregulation of IL-25, IL-33, IL-6, IL-10, and NOS2, as well as a 
significant downregulation of IL-9 was observed. A striking difference in 
the expression of IL-25, IL-33, IL-6, NOS1, NOS2, IL-2, IFN-γ, IL-4, IL-5 
and IL-9 between the infected SG
-/-
 male and female mice were found. 
This suggests that serglycin (SG) may regulate intestinal immune 
responses in a sex-dependent fashion. 
  
 
  
 
  
 
 
 
 
   
 
  
 
   
 
 
 
 
 
 
 
 
   
   
 
   vivo based  on  the in  vitro finding  where Giardia proteins  could  enhance
interaction of mast cell tryptase with Giardia should be further studied in 
Giardia through  in vivo and in  vitro experiments.  The  functional 
In  this  thesis  we  have  addressed  the  importance  of  chymase  towards 
7.1 Roles of mast cell proteases in Giardia infection
how mast cells provide protection during host defense against Giardia.
Our  studies  lay  the  foundation  for  further  addressing  the  mechanisms  on 
deficient females showed no weight gain at 12 dpi (Paper II and Paper III). 
and SG-/- mice the serum IL-6 levels were dependent on SG and the SG- 
weight loss and had similar IL-6 levels at  8 dpi  and 13 dpi. In the SG+/+ 
mMCP-4+/+  and   mMCP-4-/- mice   the   Giardia   infection   caused   similar 
The  increase  of IL-6  in  serum was associated  with  the  weight  change.  In 
chemokines  and  cytokines in the  infected  females  and  males (Paper  III). 
as  the  sex  of  the  mice  affected  the expression  levels  of  intestinal 
pronounced effect on the SG-deficient females. The SG-deficiency as well 
infection  caused  a  reduced  weight  gain mainly in  females,  with  a  more 
on the age of mice (data not shown and Paper II). In paper III the Giardia 
mice also showed a slightly different cytokine profile which could depend 
mice  lacking  mMCP-4.  Compared  to  the  young  mice,  the  mature  adult 
intestinal  chemokines  and  cytokines  were significantly  reduced  in adult 
weight  gain. In  addition, the  transcriptional  gene  expression levels of 
mature  adult  mice lost  weight  whereas  young  mice  did  not  show reduced 
proteins  could  affect  the  immune  system. Furthermore, Giardia-infected 
Collectively,  these  findings  suggest  that Giardia via  excretory-secretory 
and  that  sGPs  could  inhibit  the  neutrophil  elastase  activity  (Paper  II). 
modulate the activity of the human and mouse mast cell proteases (Paper I)
We present in vitro results showing that the sGPs and ESPs proteins could 
intestinalis and the mast cell specific proteases, i.e. tryptase and chymase. 
The studies included in this thesis cover the interactions between Giardia 
7 Conclusions and future perspectives
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the enzyme activity of tryptase. Furthermore, mast cells express several 
other proteases besides tryptase and chymase; e.g. CPA, cathepsins, 
granzyme B and MMPs. So it would also be interesting to determine the 
potential interactions between other mast cell expressed proteases and 
Giardia, to obtain more knowledge on the role of the mast cell in 
connection to the Giardia infection.  
7.2 Actions of immune cells at the core of mast cells 
during Giardia infection 
Not only mast cells but also other innate and adaptive immune cells such 
as macrophage, neutrophil, dendritic cells, T and B cells have been shown 
to be involved in host defensive mechanisms during infection with Giardia. 
Since all these different immune cells will act in a complex network of 
direct cell to cell-interactions and via cytokine signaling it would be 
interesting to study which of the receptors in the cell to cell-interactions 
and which of the cytokines that are essential to mount a successful immune 
response towards the Giardia infection.  
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Giardiasis is caused by the non-invasive intestinal protozoan parasite 
Giardia intestinalis. The parasite G. intestinalis can be found worldwide, 
but occur more frequently in developing countries. Main symptoms of an 
infection include abnormal stomach pain, vomiting, and diarrhea. The 
parasite can be transmitted among domestic animals, wild life and humans, 
usually via contaminated food or drinks. Mast cells were reported to be 
recruited during infection with Giardia, but what the mast cells do during 
the infection is still poorly understood. It is well known that mast cells 
secret or release proteases which protects against pathogenic bacteria, 
viruses and parasites.  
In this Thesis I addressed the potential roles of the mast cell-specific 
proteases in response to Giardia, using both in vitro and in vivo 
experimental models. I found that the enzymatic activities of the human 
and mouse mast cell-specific proteases were affected by soluble Giardia 
proteins (sGPs). For example, the tryptase activity was enhanced while the 
chymase activity was inhibited when sGPs were added. This suggests that 
Giardia during infection can release proteins with immunomodulatory 
capacity to change the activity of the mast cells residing in the small 
intestine. Previous studies have demonstrated that tryptase can activate the 
protease activated receptor 2 and, that chymase as well as some proteins 
secreted by Giardia can degrade tight junction proteins in the intestine. 
These actions will influence the permeability of the small intestine, effects 
that probably account for the mechanism on how Giardia causes long-term 
diarrhea. 
When using experimental mouse models, I found that infection with 
Giardia caused increased weight loss in mature adult knockout mice 
lacking the mouse mast cell protease (mMCP)-4 gene. The mouse mMCP-
4 is the functional homologue of the human chymase, and the loss of 
mMCP-4 resulted in significantly changed regulation of the intestinal 
expression of cytokines and chemokines. These results indicate that the 
mast cell chymase definitely is involved in intestinal immunity during 
infection with Giardia.  
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In addition, I found that young knockout female mice lacking the serglycin 
proteoglycan gene were more affected by the infection, with significantly 
reduced weight gain. The lack of the serglycin proteoglycan resulted in 
sex-specific changes of the intestinal cytokine and chemokines expression. 
Female mice lacking the serglycin proteoglycan showed lower expression 
of T helper cell cytokines. These results indicate that both sex-specific and 
serglycin-dependent intestinal immune responses are mounted during an 
infection with Giardia. 
In summary, soluble proteins released by Giardia can induce intestinal 
immune responses, and these immune responses are clearly modulated by 
the mast cell chymase mMCP-4 as well as by the serglycin proteoglycan. 
As next steps it would be interesting to identify the soluble Giardia 
proteins that interacts with the mast cell proteases, and to further study the 
mechanisms on how the chymase mMCP-4 and the serglycin proteoglycan 
exert their functions in vivo. Furthermore, I would like to explore if other 
mast cell proteases are affected when facing Giardia. 
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Giardia intestinalis är en icke invasiv encellig tarmparasit som orsakar 
sjukdomen Giardiasis. Parasiten G. intestinalis har global spridning men är 
vanligare och orsakar fler sjukdomsfall i utvecklingsländer. Parasiten kan 
också orsaka sjukdom i våra husdjur och vilda djur, där vi eller djuren 
vanligen får i sig parasiten via kontaminerad mat eller dryck. De 
huvudsakliga symtomen är magkramper, kräkningar och diarré.  
Ökad mastcellsaktivitet och ett mastcellberoende skydd mot infektionen 
har påvisats vid Giardiasis, men vad exakt mastceller gör under infektionen 
är fortfarande tämligen oklart. Mastceller utsöndrar flera olika specifika 
proteaser (såsom tryptas och kymas) vilka ger skydd mot sjukdomar 
orsakade av bakterier, virus, och parasiter. I avhandlingen har jag 
undersökt de mastcellspecifika proteasernas möjliga roll i immunsvaret 
mot G. intestinalis.  
I den första studien upptäckte jag att aktiviteten av proteaserna tryptas och 
kymas påverkades av utsöndrade Giardia proteiner. Aktiviteten av tryptas 
ökade och aktiviteten av kymas minskade i kontakt med de utsöndrade 
Giardia proteinerna. Detta fynd visar att G. intestinalis vid infektion 
troligen kan modulera det mastcellsdrivna inflammationsvaret i tarmen.  
I studie II använde jag knockoutmöss för att undersöka hur avsaknad av 
kymas påverkade immunsvaret i tarmen vid infektion med G. intestinalis. 
Jag undersökte framförallt immunsvaret mot G. intestinalis i gamla möss 
då detta inte undersökts förut. I möss som saknade kymaset ”mouse mast 
cell protease” (mMCP)-4 fann jag en signifikant förändrad cytokinprofil i 
tarmen, där uttrycket av många undersökta cytokiner var reducerat i 
jämförelse med de möss som hade kymaset kvar i tarmen. Detta visar att 
kymas i gamla möss bidrar till immunsvaret i tarmen vid Giardiasis. 
I studie III använde jag knockoutmöss för att undersöka hur avsaknad av 
serglycin påverkade immunsvaret i tarmen vid infektion med G. 
intestinalis. Proteoglykanen serglycin är viktig i flera immuncelltyper för 
inlagring i granula av flera olika positivt laddade proteaser. Avsaknad av 
Populärvetenskaplig sammanfattning 
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serglycin ger därför upphov till starkt reducerade mängder av många av 
dessa proteaser i immuncellerna. I unga honmöss som saknade serglycin 
fann jag en starkt reducerad viktminskning och en i huvudsak nedreglerad 
cytokinprofil i tarmen, jämfört med de honmöss som hade serglycin kvar i 
tarmen. Vidare visade hanmöss som saknar serglycin ett ökat uttryck av de 
flesta av de undersökta cytokinerna. Denna studie visar att både serglycin 
och kön kan påverka immunsvaret i tarmen under Giardiasis. 
Sammanfattningsvis så verkar utsöndrade Giardia proteiner inducera och 
reglera immunsvaret i tarmen. Dessutom påverkar kymas och serglycin 
immunsvaret. I mina nästa steg skulle jag vilja identifiera de utsöndrade 
Giardia proteinerna som påverkar mastcellsproteaserna, och mer i detalj 
undersöka hur kymas och serglycin utför sina funktioner in vivo. Det skulle 
också vara intressant att undersöka de andra mastcells-specifika 
proteaserna i svaret mot Giardia. 
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A B S T R A C T
Background: Mast cells are involved in the host immune response controlling infection with the non-invasive
intestinal protozoan parasite Giardia intestinalis. Experimental infections in rodents with G. intestinalis showed
increased intestinal expression of mucosal and connective mast cell specific proteases suggesting that both
mucosal and connective tissue mast cells are recruited and activated during infection. During infection Giardia
excretory-secretory proteins (ESPs) with immunomodulatory capacity are released. However, studies in-
vestigating potential interactions between Giardia ESPs and the connective tissue mast cell specific serine pro-
teases, i.e. human chymase and mouse mast cell protease (mMCP)-4 and, human and mouse tryptase (mMCP-6)
remain scarce.
Results: We first investigated if soluble Giardia proteins (sGPs), which over-lap extensively in protein content
with ESP fractions, from the isolates GS, WB and H3, could induce mast cell activation. sGPs induced a minor
activation of bone marrow derived mucosal-like mast cells, as indicated by increased IL-6 secretion and no
degranulation. Furthermore, sGPs were highly resistant to degradation by human tryptase while human chymase
degraded a 65 kDa sGP and, wild-type mouse ear tissue extracts degraded several protein bands in the 10 to
75 kDa range. In striking contrast, sGPs and ESPs were found to increase the enzymatic activity of human and
mouse tryptase and to reduce the activity of human and mouse chymase.
Conclusion: Our finding suggests that Giardia ssp. via enhancement or reduction of mast cell protease activity
may modulate mast cell-driven intestinal immune responses. ESP-mediated modulation of the mast cell specific
proteases may also increase degradation of tight junctions, which may be beneficial for Giardia ssp. during
infection.
1. Introduction
Mast cell activation and degranulation to microbial and parasitic
infections may occur by several mechanisms, i.e. via PAMPs and alar-
mins (DAMPs) acting over pattern recognition receptors, or via com-
plement- and antibody-dependent mechanisms (Redegeld et al., 2018).
When mast cells degranulate large quantities of preformed mediators
are released, e.g. the mast cell specific proteases. Of the mast cell spe-
cific proteases tryptases and chymases may constitute up to as much as
35–50% of the mast cell protein content (Pejler et al., 2010). In the
mouse mast cells predominantly express four different chymases: in
mucosal tissue mast cells express the mouse mast cell protease (mMCP)-
1 (Mcpt1) with chymotrypsin-like activity and mMCP-2 (Mcpt2) with as
yet no identified enzymatic activity and; in connective tissue mast cells
express the mMCP-4 (Mcpt4) with chymotrypsin-like activity and
mMCP-5 (Mcpt5) with elastase-like activity. In contrast, human mast
cells express only one chymase gene and the closest functional ortholog
in mice is the chymase mMCP-4. Mouse and human mast cells express
three tryptase genes, i.e. the mouse mast cell proteases (mMCP)-6Mcpt6
which is closely related to human TPSAB1/A1 and, mMCP-7 (Tpsab1)
closely related to human TPSD1 as well as mTMT (Tpsg1) closely related
to the human TPSG1 gene (Pejler et al., 2007). The C57BL/6 mouse
strain carries a disrupted mMCP-7 gene due to a splicing defect and a
gene knockout of mMCP-6 has been introduced on the C57BL/6 back-
ground. The lack of both mMCP-6 and mMCP-7 caused no major pro-
blems for unchallenged mice suggesting that the mast cell specific
tryptases are not essential for survival. However, challenged mMCP-6-
deficient mice displayed significant inability to recruit eosinophils in
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chronically Trichinella spiralis infected skeletal muscle tissue (Shin et al.,
2008). In another recent study, it was suggested that the termination of
the helminth Strongyloides ratti infection required the presence of mu-
cosal mast cells, because infection lasted longer in CPA3Cre mice which
lack mucosal and connective tissue mast cells than in Mcpt5Cre R-DTA
mice which only lack connective tissue mast cells (Reitz et al., 2017).
Giardia intestinalis is a relatively prevalent non-invasive intestinal
protozoan parasite with zoonotic potential found worldwide that can
cause diarrhea and growth stunting in humans and animals (Luján and
Svärd, 2011). G. intestinalis parasite antigens, either on the surface or
excreted-secreted products, have been shown to be immunogenic (Kaur
et al., 1999). Giardia-infection and Giardia excretory-secretory proteins
(ESPs) induced IL-4, IL-5 and IL-10 cytokine responses as well as IgG
and IgE antibody responses in BALB/c mice (Jimenez et al., 2014). ESPs
induced IL-8 production in a human gastrointestinal cell line (HT-29)
via activation of p38, ERK1/2, nuclear factor kappaB and activator
protein 1 (Lee et al., 2012). Several other chemokines (e.g. CXCL 1–3,
CCL2 and 20) are up-regulated by ESPs in differentiated Caco-2 cells
(Ma’ayeh et al., 2017). In addition, antibody responses to several
Giardia glycoproteins have been identified in the serum of immunized
BALB/c mice (Jimenez et al., 2007). Furthermore, glycoproteins with
immunomodulatory capacity and proteolytic activity have been iden-
tified in the excretory-secretory proteins from Giardia trophozoites
(Ma’ayeh et al., 2017; Ward et al., 1988; Ortega-Barria et al., 1990;
Hiltpold et al., 2000; de Carvalho et al., 2008; Cabrera-Licona et al.,
2017; Liu et al., 2018; Dubourg et al., 2018). During infections with
Giardia ssp. mast cells are recruited to the intestine (Li et al., 2016) and
compared to wild-type mice c-kit-dependent mast cell-deficient mice (c-
kitw/wv) and anti-c-kit mast cell depleted mice showed increased
parasite burden and failure to produce parasite-specific IgA antibodies
(Li et al., 2004; Munoz-Cruz et al., 2010). In addition, mast cell specific
proteases were among the most obviously induced transcripts in the
small intestinal tissue at 13 days post infection (Tako et al., 2013). Mast
cells are also recruited to the small intestinal mucosa during Giardia
infections in humans (Nicolov et al., 1983), gerbils (Leitch et al., 1993;
Hardin et al., 1997) and rats (Halliez et al., 2016). Stimulation of the rat
mast cell line HRMC with soluble Giardia protein extracts (sGPs) which
overlap extensively in protein content with Giardia ESPs (Ma’ayeh
et al., 2017; Dubourg et al., 2018), triggered mast cell activation and
up-regulation of tryptase (Munoz-Cruz et al., 2010; Munoz-Cruz et al.,
2018). Collectively, these results suggest that mast cells and the mast
cell specific proteases may play a significant role in the host immune
responses against G. intestinalis. However, if Giardia via secretion of
ESPs and other soluble proteins directly interacts with the mast cell
specific proteases remain unknown. Therefore, in this study we in-
vestigated the activities of human and mouse mast cell tryptase and
chymase towards soluble Giardia protein extracts (sGPs) from the iso-
lates GS and H3 (both assemblage B) and WB (assemblage A) and, ESPs
from the GS and WB isolates.
2. Material and methods
2.1. Ethics and mice
Animals were kept in agreement with the Swedish Animal Welfare
Act under the permission C140/15 granted by Uppsala District Court.
Heterozygote mice of the mouse mast cell protease 6-deficient (mMCP-
6−/−) mouse strain on the C57BL/6J Taconic background were crossed
to produce littermate (Shin et al., 2008) mMCP-6+/+ and mMCP-6−/−
mice from which ear tissue materials to be used in the enzymatic pro-
tease activity assays were collected. Bone marrow for generation of
bone marrow-derived mucosal-like mast cells (BM-MMC) was obtained
from five of the in house bred mMCP-6+/+ C57BL/6J Taconic mice. All
mice were housed at the Faculty of Veterinary Medicine and Animal
Science, SLU, Uppsala, Sweden under specific pathogen free conditions
in an enriched environment and provided food and water ad libitum.
2.2. Bone marrow derived mast cells: preparation, culture and in vitro
stimulation
To obtain bone marrow derived mucosal-like mast cells (BM-
MMCs), bone marrow cells was collected from femur and tibia. The cells
were washed two times in PBS and cultured in complete Dulbecco’s
modified Eagle’s medium (DMEM) supplemented with 10% FCS, 1%
PEST, 2mM L-glutamine, 5 ng/ml mouse interleukin (IL) -9
(ImmunoTools), 1 ng/ml recombinant human transforming growth
factor beta (TGF-beta, ImmunoTools), 1 ng/ml mouse IL-3
(ImmunoTools) and 50 ng/ml mouse stem cell factor (SCF,
ImmunoTools). After two weeks> 99% of the cells showed BM-MMCs
characteristics as verified by May-Grünwald/Giemsa staining. The BM-
MMCs were washed three times in PBS and seeded in duplicates (first
experiment) or triplicates (second experiment) at 2×106 BM-MMCs/
ml in HBSS and challenged with different concentrations (25 ng/ml,
100 ng/ml and 1 μg/ml) of soluble protein extracts from three different
Giardia isolates (GS, WB and H3). After 6 h or 24 h incubation (at 37 °C,
5% CO2), supernatants were collected and frozen at −20 °C until used.
2.3. Preparations of soluble Giardia proteins and Giardia excretory-
secretory proteins
To get soluble Giardia proteins (sGPs), Giardia assemblage A (WB-
C6, ATTC 50803) and B (GS/M, ATTC 50581 and H3) trophozoites were
grown separately at 37 °C in Diamond- and Keister media (TYDK media)
supplemented with 10% sterile bile, 10% heat inactivated bovine serum
(FBS, Gibco, Thermo FisherScientific, MA, USA) and 1% Ferric am-
monium citrate solution with the final pH adjusted to 6.8 (Keister,
1983). Trophozoites were collected after three washing steps with cold,
sterile phosphate-buffered saline (PBS) by pelleting with centrifugation
at 931×g at 4 °C for 10min. The pellet was re-suspended in PBS, fol-
lowed by sonication (3 times for 30 s at 50W) and centrifuged at
14462×g at 4 °C for 15min to remove cell debris. The supernatants
containing approximately 5 μg/μl of sGPs were kept at −80 °C until
used.
Giardia excretory-secretory proteins (ESPs) were obtained from G.
intestinalis as described (Ma’ayeh et al., 2017). In brief, WB and GS
trophozoites cultured for 48 h at 37 °C in TYDK medium were rinsed
three times with warm and serum-free RPMI-1640 medium (Sigma, St.
Louis, MO, USA) to eliminate non-attached or dead trophozoites.
Thereafter, adherent trophozoites were incubated with RPMI-1640
medium supplemented with 11.4mM L-cysteine hydrochloride mono-
hydrate, 55.5 mM glucose, 11.4mM ascorbic acid, 1 mM sodium pyr-
uvate (Gibco), 22.8 mM L-arginine, 2mM Glutamax (Gibco) and 1x
MEM essential amino acids. The final pH of the supplemented media
was set at 6.8 and the trophozoites were incubated for 6 h at 37 °C.
Trophozoite viability was assessed at 90% and culture supernatants
were harvested by centrifugation at 930×g for 10min at 4 °C, filtered
through Amicon® Ultra 15ml centrifugal filters with 3 kDa cut-off
(Merck-Millipore, Darmstadt, Germany), concentrated down to
200–300 μl with a final concentration of approximately 1 μg/μl of ESPs,
and stored at −80 °C until used.
2.4. ELISA assay for IL-6 detection
The concentration of IL-6 was determined in supernatants from
Giardia-challenged and un-challenged BM-MMCs using a mouse IL-6
ELISA developmental kit (#900-T50, PeproTech), according to sup-
plier´s protocol.
2.5. β-hexosaminidase measurement
For the β-hexosaminidase assay, 20 μl of cell culture supernatants
were incubated with 80 μl of 1mM substrate (p-nitrophenyl N-acetyl-
beta-D-glucosamine, #487052, Merck KGaA, Germany) dissolved in
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citrate buffer (0.05M citric acid and trisodium citrate, pH 4.5) for 1 h at
37 °C, followed by addition of 200 μl 0.05M sodium carbonate reaction
buffer (Na2CO3 and NaHCO3, pH 10.0). Absorbance was measured at
405 nm.
2.6. Cell viability
BM-MMCs were stained for five minutes with 0.02% trypan blue,
dead blue cells were counted and cell viability for BM-MMCs was cal-
culated.
2.7. Purification of mouse proteolytic ear tissue protein extracts
The purification method was as described before (Roy et al., 2014).
Briefly, ear tissues from mMCP-6+/+ (n=10 per preparation) and
mMCP-6−/− mice (n= 10 per preparation) were frozen in liquid ni-
trogen and crushed into a tissue powder with a mortar and pestle and
then transferred to a 15ml tube. To enrich for mast cell protease ac-
tivities, the ear tissue powder was first extracted with a low salt lysis
buffer (PBS/1% Triton X-100) to remove the fraction of ear tissue
proteins not binding to negatively charged glycosaminoglycan chains
found on proteoglycans. After 30min on a rocking table at ambient
temperature, lysed tissues were centrifuged at 3000 rpm for 10min.
The fragmented pelleted ear tissues were then extracted with a high salt
lysis buffer (PBS/2M NaCl/1% Triton X-100). After shaking for 30min
at room temperature and centrifugation at 3000 rpm for 10min, high
salt supernatants containing enriched mast cell protease activities were
collected and kept at −20 °C until used.
2.8. Degradation assay of GS, WB, and H3 soluble Giardia proteins
Enzymatic degradation of sGPs was analyzed by mixing 20 μg of
sGPs with 0.2 μg of recombinant human tryptase (rHT, Promega) or
with 0.05 μg or 0.4 μg recombinant human chymase (rCh, a kind gift
from Lars Hellman, ICM, Uppsala University), or with 5 μg of crude
wild-type ear tissue extracts and incubated at 37 °C for 3 h or overnight.
As a control of intrinsic degradation activity in sGPs 20 μg of sGPs were
incubated at 37 °C for 3 h or overnight. Enzymatic and intrinsic de-
gradation of the sGPs was visualized on colloidal Coomassie blue
stained SDS-PAGE gels.
2.9. SDS-PAGE electrophoresis and colloidal Coomassie blue staining
The 3 h and overnight samples containing the 20 μg sGPs incubated
with or without proteolytic activity was loaded on SDS-PAGE gels and
the gels were run according to standard procedures. The gels were
stained in Coomassie solution (0.1% Coomassie brilliant blue R-250/
50% methanol/ 10% Acetic acid) for at least 4 h, and de-stained in 10%
acetic acid/40% EtOH/50% dH2O for 30min with several changes of
the de-staining solution. Photos of the de-stained gels were taken with
the Odyssey CLx imaging system (Germany).
2.10. Soluble Giardia proteins and mast cell protease activity
Early work showed that the activity of the chymase and tryptase
could be affected by salt concentrations (NaCl) as well as pH (McEuen
et al., 1995; Ren et al., 1998; Addington and Johnson, 1996). Therefore,
in all our experiments the NaCl concentrations were kept in the phy-
siological range of 0.15 to 0.20M NaCl and the pH was kept at ≈7,4.
To address if Giardia via sGPs or ESPs could block or modulate the
tryptase activity, 5 μg ESPs from the GS and WB isolates or approxi-
mately 20, 10, 5 and 1 μg of WB, GS and H3 sGPs (5 μg/μl) were mixed
with 0.1 μg of recombinant human tryptase (rHT) or approximately
15 μg of crude high salt ear tissue extracts from mMCP-6+/+ and
mMCP-6−/− mice (tryptase-deficient mice) and 20 μl of the tryptase
substrate S-2288 (H-D-Ile-Pro-Arg-pNA, Chromogenic, Sweden) at a
final concentration of 1mM, and PBS to give the total 120 μl reaction
volume. Enzymatic activity of tryptase was measured as hydrolysis of S-
2288 and monitored spectrophotometrically at 405 nm in a microplate
reader. The change in optical density over time (delta OD) and the
substrate conversion rate (delta OD per minute) was calculated.
To determine if Giardia via sGPs or ESPs affected the chymase ac-
tivity, 5 μg ESPs of GS and WB or approximately 10 μg of WB, GS and
H3 sGPs were mixed with 0.05 μg of recombinant human chymase (rCh)
or approximately 5 μg of crude high salt ear tissue extracts from mMCP-
6+/+ mice and 20 μl of the chymase substrate L-1595 (Suc-Ala-His-Pro-
Phe-pNA, Bachem, Switzerland) at a final concentration of 1mM, and
ddH2O to give the total 120 μl reaction volume. Enzymatic activity of
chymase was measured as hydrolysis of L-1595 and monitored spec-
trophotometrically at 405 nm in a microplate reader. The change in
optical density (OD) over time (deltaOD) was calculated.
2.11. Statistical analysis
Statistical analysis of data was performed with GraphPad Prism
Software using the non-parametric Mann-Whitney U test. P values ≤
0.05 were considered significant.
3. Results
3.1. Soluble Giardia proteins (sGPs) only cause minor mast cell activation
Mast cells and mast cell proteases are important for control of in-
fection with Giardia spp. (Li et al., 2016; Li et al., 2004), and mast cells
may degranulate in response to soluble proteins from protozoan para-
sites (Bidri et al., 1997). To address a direct interaction between mouse
mast cells and G. intestinalis, bone marrow derived mucosal-like mast
cells (BM-MMCs) were challenged with increasing concentrations of
soluble proteins (sGPs) from G. intestinalis GS-, WB-, and H3- isolates. As
a read out of mast cell activation and mast cell degranulation the levels
of IL-6, and tryptase and beta-hexosaminidase activity were determined
in the BM-MMC supernatants. Challenge with the three Giardia-isolates
induced a significant increase in IL-6 release at 6 h and at 24 h (Fig. 1a,
b), and a small but significantly increased tryptase activity with 1 μg of
sGPs (Fig. 1c, d). The challenge with sGPs did not induce degranulation
of the BM-MMC (Fig. 1e, f and data not shown) and the cell viability
remained equally high in control cells and sGP-challenged cells (Fig. 1g,
h). Together our data suggests that sGPs can induce mast cell activation
and that the challenge does not induce mast cell degranulation but may
induce piecemeal secretion of tryptase.
3.2. Soluble Giardia proteins (sGPs) are not extensively degraded by human
or mouse mast cell proteases
To investigate the potential interactions between the mast cell
specific proteases and Giardia proteins we next studied if any of the
sGPs were degraded by recombinant human tryptase (rHT) or wild-type
proteolytic mouse ear tissue extracts. rHT did not induce any major
degradation of the GS-, WB-, H3- sGPs after 3 h (Fig. 2a, lanes 4, 7, 10)
or after extended overnight incubation (Fig. 2b, lanes 4, 7, 10). Fur-
thermore, except for a 65 kDa sized protein a high concentration of
recombinant human mast cell chymase (rCh) also failed to degrade
most of the sGPs after 24 h (Fig. 2c, lanes 2, 4, 6), suggesting that sGPs
are poor target substrates for the mast cell specific tryptase and chy-
mase. In contrast, the high salt ear tissue proteolytic extracts showed a
diffuse degradation activity of the sGPs in the 10–75 kDa range, e.g. a
≈45kDa protein was significantly reduced (Fig. 2a, b, lanes 5, 8, 11),
suggesting that the mixture of proteolytic enzymes in the ear tissue
extracts can degrade sGPs. Note also that the sGPs did not carry any
major intrinsic degradation activity.
The lack of degradation by chymase and tryptase could indicate that
Giardia proteins are devoid of the defined extended target sites required
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for these mast cell proteases to cut. However, the top 10 secreted
peptides from WB and GS trophozoites (Ma’ayeh et al., 2017) all con-
tained several of the potential chymase and tryptase target sites (not
shown), but it is possible that these sites are hidden in the three
dimensional protein structure. Alternatively, sGPs may block the pro-
teolytic activities of the mast cell specific tryptase and chymase.
3.3. Soluble Giardia proteins (sGPs) and excretory-secretory proteins
(ESPs) enhance recombinant human tryptase activity
Next we investigated if sGPs and Giardia excretory-secretory pro-
teins (ESPs) could have a modulatory effect on the mast cell protease
activities. Surprisingly, we observed an enhancing effect on the tryptase
activity (Fig. 3) and the enhancing effect on rHT activity was dose
dependent and required the addition of> 5 μg of sGPs (Fig. 3a). Ad-
dition of 20 μg GS, WB and H3 sGPs resulted in a significant increase of
rHT activity over 60min, where the sGPs-effect on the S-2288 substrate
conversion was evident after 15min, and the substrate conversion rate
significantly was increased up to at least 50min after addition of sGPs
(Fig. 3b, c). Note that the GS, WB and H3 sGPs showed no intrinsic
activity for the S-2288 substrate. To evaluate if the observed increased
activity of rHT is due to proteins found in the Giardia excretory-secre-
tory proteins (ESPs) we next used purified ESPs (Ma’ayeh et al., 2017)
from the Giardia isolates GS and WB. Addition of ESPs also gave a
significantly increased S-2288 substrate conversion rate for rHT
(Fig. 3d), suggesting that the protein(s) responsible for the enhance-
ment activity is to be found in the ESPs. Note that the GS and WB ESPs
showed no intrinsic activity for the S-2288 substrate. Compared with
the control (PBS/rHT/S), addition of both GS and WB ESPs significantly
increased enzymatic activity of rHT already after 15min and the ac-
tivity rate were still significantly higher after 60min (Fig. 3e).
3.4. Soluble Giardia proteins (sGPs) enhance mouse mast cell tryptase
activity
Seeing the enhancement effect on the human tryptase activity, we
next assessed if secreted Giardia proteins could also enhance the mouse
mast cell tryptase activity. High salt ear tissue protein extracts from
wild-type mice were incubated with sGPs derived from the GS (Fig. 4a),
WB (Fig. 4b) or H3 (Fig. 4c) isolates. High salt ear tissue protein ex-
tracts from the mMCP-6−/− mice as well as rHT were included as ne-
gative and positive controls, respectively. Addition of the three sGP-
isolates induced a significantly increased mouse tryptase activity
(Fig. 5a–c, left panels). As expected ear tissue protein extracts from
mMCP-6−/− mice showed little tryptase activity (S-2288 substrate
conversion rate) and no significantly increased substrate conversion
after addition of sGPs, suggesting that the substrate S-2288 is relevant
for measurement of tryptase activity even in complex protein mixtures
(Fig. 4a–c, left panels). The enhancement of mouse mast cell tryptase
activity over time after addition of sGPs was also studied. We found that
the OD values for (sGPs/WT/S-2288) were significantly increased
compared to control (WT/S-2288) suggesting that all three sGP-isolates
over time can enhance tryptase activity or, alternatively, increase the
stability of the tryptase tetramer (Fig. 4a–c, right panels).
3.5. Soluble Giardia proteins (sGPs) reduce human and mouse mast cell
chymase activity
Finally we investigated if sGPs and ESPs could modulate the mast
cell chymase activity. Interestingly, and in contrast to the enhancing
Fig. 1. Soluble Giardia proteins induce secretion of IL-6 and tryptase in bone marrow derived mucosal type mast cells (BM-MMCs). To determine if Giardia activates
mast cells 1× 106 BM-MMCs seeded in 0.5ml HBSS were challenged with three concentrations, 25 ng/ml, 100 ng/ml and 1000 ng/ml, of soluble Giardia proteins
(sGPs) from the GS-, WB- and H3- isolates. The levels of IL-6 (a, b with N=5), tryptase activity (c, d with N=5), and beta-hexosaminidase activity (e, f with N=3)
were determined in supernatants collected at 6 h (a, c, e) and 24 h (b, d, f). Tryptase activity was evaluated by the conversion of the substrate S-2288 and recorded as
changes in optical density (OD) at 405 nm. BM-MMCs viability was scored by trypan blue exclusion at 6 h (g) and 24 h (h). Data is pooled from two independent
experiments with BM-MMCs derived from a total of five individual mice (N=5), in duplicate cultures (from two mice in first experiment, n= 4) or triplicate cultures
(from three mice in second experiment, n= 9). Data are shown as mean ± SEM and statistical analysis conducted by the non-parametric Mann-Whitney U test with
significant difference indicated as *, P < 0.05, **, P < 0.01, ***, P < 0.001, ****, P < 0.0001 versus un-challenged control.
Fig. 2. Soluble Giardia proteins are not extensively degraded by human tryptase
or chymase, or by wild type mouse ear tissue proteolytic extracts. To determine
if mast cell proteases can degrade Giardia proteins, 20 μg of soluble Giardia
proteins (sGPs) were incubated with 0.2 μg recombinant human tryptase (rHT,
arrow) or with 5 μg of proteolytic mouse ear tissue extracts (WT, pooled ear
tissue extracts, n= 10) for (a) 3 h and (b) overnight (O.N.). Left panels in (a)
and (b) are longer exposures of the gels to visualize the loading of rHT (arrows)
and WT ear tissue extracts. In panels a and b lanes are numbered and loaded as
follows (1- rHT; 2- WT; 3- GS; 4- GS+ rHT; 5- GS+WT; 6- WB; 7- WB+ rHT;
8- WB+WT; 9- H3; 10- H3+rHT; 11- H3+WT). In (c) 20 μg of soluble Giardia
proteins of the GS, WB and H3 isolates were incubated without or with 0.4 μg
recombinant human chymase (rCh) overnight. In panel c lanes are numbered
and loaded as follows (1- GS; 2- GS+ rCh; 3- WB; 4- WB+ rCh; 5- H3; 6-
H3+rCh; 7- rCh).
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Fig. 3. Soluble Giardia proteins and excretory-secretory proteins mediate enhancement of human tryptase activity. Different concentrations of soluble Giardia
proteins (sGPs) from the GS, WB and H3 isolates (a, b) or 5 μg of GS and WB excretory-secretory protein (ESP) (c, d) were incubated with or without 0.02 μg of rHT.
The change in optical density (OD) was measured at 405 nm after adding the substrate (S-2288, S) and the difference over time (deltaOD) calculated. Note that sGPs
and ESPs have no intrinsic activity for the S-2288 substrate. In (a) a representative experiment out of> 5 independent experiments is shown and in (b and c) a
representative experiment out of 3 independent experiments is shown. In (d) the enzyme activity rate in figure c was determined as milli-delta OD per minute. Note
that addition of ESPs significantly increased the tryptase activity rate already after 15min and maintained a significantly increased rate also at 60min.
Representative data from two independent experiments with triplicates for each condition are shown as mean ± SEM, and statistical analysis was conducted by the
non-parametric Mann-Whitney U test. Statistical significances compared to PBS/rHT/S: *, P < 0.05, **, P < 0.01, ***, P < 0.001.
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effect on tryptase, addition of 10 μg of GS, WB and H3 sGPs significantly
inhibited the rCh activity (Fig. 5a) and resulted in inhibition of chymase
activity also in the WT mouse ear tissue extracts (Fig. 5b). Note that
sGPs have no intrinsic activity for the L-1595 chymase substrate (not
shown). To evaluate if the observed reduced activity of rCh is due to
Giardia proteins found in the ESP fraction we finally used ESPs from the
Giardia isolates GS and WB. However, the addition of ESPs did not
significantly affect the rCh activity (Fig. 5c).
4. Discussion
Previous studies have suggested that mast cells play an important
role during infection with Giardia. Mast cell-deficient and mast cell-
depleted mice showed clearance failure of the GS isolate (assemblage B)
and recruited mast cell numbers increased in the intestinal villi and
crypt of mice infected with the GS isolate (Li et al., 2016; Li et al., 2004;
von Allmen et al., 2006). Furthermore, the mast cell specific proteases
CPA3 as well as Mcpt1, Mcpt2 and CMA2 were reported to be up-
regulated during infection with Giardia, suggesting that both connective
and mucosal tissue type mast cells have increased activity in the in-
testinal tissue in response to Giardia (Tako et al., 2013).
However, it still remains unknown if the GiardiaWB (assemblage A)
or H3 (assemblage B) isolates cause mast cell activation in vivo and, the
potential direct interactions of Giardia with the mast cell specific pro-
teases have previously not been explored. First, to study potential in-
teractions between Giardia and mast cells we cultured mouse bone
marrow derived mucosal-like mast cells (BM-MMCs) expressing both
connective and mucosal mast cell specific proteases (Braga et al., 2007)
to investigate the potential activation of mast cells after challenge with
G. intestinalis sGPs. Challenge with Giardia sGPs caused IL-6 secretion
after 6 h suggesting that our cultured BM-MMCs do respond to Giardia
sGPs. In addition, the low levels of tryptase activity in BM-MMCs su-
pernatants suggested that Giardia does not cause strong mast cell
Fig. 4. Soluble Giardia proteins enhance mouse mast cell tryptase activity. sGPs
were incubated with or without 002 μg of rHT or with 15 μg of ear tissue ex-
tracts from WT mice (bulk ear tissue extracts, n= 10) and mMCP6−/− mice
(bulk ear tissue extracts, n=10) at room temperature, respectively. (a) GS
(upper panels), (b) WB (middle panels) and (c) H3 (lower panels). The left
panels in a, b, c show the tryptase activity of the high salt mouse ear tissue
extracts mixed with or without 10 μg sGPs from the GS, WB and H3 isolates.
rHT was included as a positive control. Change in optical density (OD) at
405 nm was measured at time point 0 h and 4 h after the S-2288 substrate was
added. Data are shown as mean ± SEM and statistically significant enhance-
ment compared to WT ear tissue extracts indicated with *, P < 0.05. The right
panels in a, b, c show the activity of WT ear tissue extracts (WT) mixed with or
without 5 μg of sGPs from the GS, WB and H3 isolates. Change in optical density
(OD) at 405 nm was measured every hour up to 11 h and after 24 h. Note that
GS, WB and H3 sGPs have no intrinsic activity for the S-2288 substrate. Pooled
data from two independent experiments with triplicates for each condition are
shown as mean ± SEM and, statistically significant enhancement compared to
WT ear tissue extracts without sGPs indicated with *, P < 0.05, **, P < 0.01,
***, P < 0.001, ****, P < 0.0001.
Fig. 5. Soluble Giardia proteins inhibit human and mouse chymase activity. (a)
The activity of 0.05 μg of recombinant human chymase (rCh) incubated with or
without 10 μg of GS, WB and H3 sGPs. (b) The chymase activity in 5μg wild-
type mouse ear tissue (WT, pooled ear tissue extracts, n=10) with or without
10 μg of GS, WB and H3 sGPs. (c) The activity of 0.05 μg rCh incubated with or
without 5μg of GS and WB ESPs. The change in optical density (OD) at 405 nm
was measured after adding the chymase substrate (L-1595, L) and the difference
over time (delta OD) calculated. Pooled data from two independent experi-
ments with triplicates for each condition are shown as mean ± SEM. **,
P < 0.01, ****, P < 0.0001.
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degranulation, but instead may cause increased piecemeal secretion of
tryptase as augmented tryptase activity was only evident after chal-
lenge with sGPs. The observation that Giardia sGPs did not cause de-
granulation of the mast cells, i.e. as indicated with very low tryptase
activity, was further supported by a similarly low beta-hexosaminidase
activity in the supernatants of un-challenged and challenged BM-MMCs.
Previous studies using a rat hybridoma mast cell line (HRMC) with a
mucosal phenotype showed that IL-6 was secreted 24 h after challenge
(Munoz-Cruz et al., 2010; Munoz-Cruz et al., 2018). In contrast to our
results, these studies suggested that the level of tryptase only increased
beneath the mast cell cell-membrane in response to Giardia challenge
(Munoz-Cruz et al., 2010; Munoz-Cruz et al., 2018).
Several studies have demonstrated that Giardia soluble proteins
(sGPs) contain cytosolic, cytoskeletal, surface and excretory-secretory
proteins (ESPs), and that the secretion of ESPs will be induced upon
contact with epithelial cells in the small intestine (Ma’ayeh et al., 2017;
Dubourg et al., 2018; Jimenez et al., 2009; Ringqvist et al., 2008), and
that some of the ESPs may penetrate into the host tissue (Ma’ayeh et al.,
2017; Liu et al., 2018). Previous studies suggested an extensive over-lap
in protein content between the two in vitro prepared fractions. One
difference, ESPs contained several surface proteins that were not found
in the sGPs fraction (Ma’ayeh et al., 2017; Dubourg et al., 2018; Emery
et al., 2016). In line with this extensive over-lap we see similar effects of
ESP and sGPs on tryptase activity (Figs. 3 and 4). For chymase the in-
hibitory effect of sGPs was not evident with the ESPs (Fig. 5). The ob-
served difference could depend on several things, for example that ESPs
may lack the chymase interfering protein(s). Alternatively, Giardia ex-
presses several cysteine proteases/cathepsin-like proteases (CPs) in the
ESPs that potentially could degrade chymase. However, these CPs are
subjected to rapid auto-degradation (Liu et al., 2018). So, lack of chy-
mase-inhibition with ESPs could depend on the rapid auto-inactivation
of the CPs.
Giardia has been found to secrete several different proteins (ESPs) at
low levels in axenic culture and, in the interaction with human in-
testinal epithelial cells (IECs) the ESPs have the capacity to modulate
the host innate immune response, e.g. it was found that ESPs could
stimulate a preferential Th2 response (Jimenez et al., 2004), degrade
chemokines and induce the anti-inflammatory protein tristetraprolin
(TTP) (Ma’ayeh et al., 2017). The ESP fraction from the WB isolate
contains around 200 different proteins (Ma’ayeh et al., 2017) and most
of these proteins are also found in the soluble Giardia protein fractions
(Dubourg et al., 2018). It is difficult to generate high levels of ESPs from
Giardia due to the low level of secretion (Ma’ayeh et al., 2017), this has
led to the use of soluble proteins as a substitute for ESPs in most ex-
periments looking at Giardia-immune cell interactions.
We therefore investigated a potential interaction of the mast cell
specific proteases tryptase and chymase with Giardia proteins.
Collectively our findings suggest that Giardia via release of ESPs may
directly affect the mast cell tryptase activity. Therefore, it is possible
that due to the disturbed intestinal epithelial barrier caused by the
Giardia infection (Liu et al., 2018), Giardia ESPs can reach into the
intestinal tissue and thereby increase the level and activity of the mast
cell tryptase. An increase in tryptase activity can in turn even more
increase the epithelial leakage (Fernandez-Blanco et al., 2015), thereby
resulting in a leaky gut that can induce diarrhea and post-infectious
symptoms (Fink and Singer, 2017; Allain et al., 2019; Halliez and Buret,
2013). Several post-infectious symptoms can be induced after Giardia
infections; irritable bowel syndrome (IBS), chronic fatigue syndrome,
skin and food allergies and reactive arthritis (Litleskare et al., 2019;
Litleskare et al., 2018; Painter et al., 2017; Di Prisco et al., 1998; Chirila
et al., 1981; Mahmoud et al., 2004). Mast cells could be very important
in the allergies induced after a Giardia infection and humans and mice
infected by Giardia induce Giardia-specific IgE responses and ESPs have
been suggested to be involved in IgE induction (Jimenez et al., 2014;
Jimenez et al., 2009; Matowicka-Karna et al., 2009). It will be inter-
esting to follow up the role of mast cells in the induction of post-
infectious symptoms in larger studies.
It is well known that activation of mast cells during infection release
extensive amounts of preformed mediators. The mast cell proteases can
play regulatory roles through degradation of parasite antigens, e.g. the
T. spiralis heat shock protein 70, as well as through activation or in-
activation of endogenous cytokines and alarmins, i.e. biglycan, HMGB1
and IL-33 all seem to be rapidly degraded by the mast cell specific
chymase (Roy et al., 2014). However, while chymase rapidly degraded
most T. spiralis proteins as well as the alarmins and the HSP70, tryptase
was not very effective in the degradation of these proteins (Roy et al.,
2014). In line with this, Giardia sGPs were highly resistant to de-
gradation with tryptase, however the resistance of most of the soluble
Giardia proteins to degradation by mast cell chymase was an un-
expected finding.
The mast cell specific chymase is monomeric and the extended
target site for chymase is eight amino acids long (P4, P3, P2, P1, P1’,
P2’, P3’, P4’). Chymase prefers to cut after aromatic amino acids phe-
nylalanine (F), tryptophan (W) or tyrosine (Y) located in the P1 position
and usually require aspartic acid (D) or glutamic acid (E) in the P2’
position (Andersson et al., 2008; Andersson et al., 2009; Andersson
et al., 2010). However, physiologic targets for degradation by chymase
remain elusive but some virulence factors and alarmins seems to be
major targets (Roy et al., 2014; Fu et al., 2017). In addition, activation
of matrix metalloprotease (MMP)-9 and angiotensin seems to require
chymase (Tchougounova et al., 2005). Chymase binds strongly to he-
parin (or chondrotin sulphate E) and it has been suggested that chy-
mase and heparin forms a functional complex that can leave the mast
cell after degranulation and move into inflammatory or other body
sites. For example, in bladder infection with uropathogenic bacteria
chymase is released by mast cell degranulation, and then the chymase
migrates and enter into the infected umbrella epithelial cells lining the
bladder wall to induce apoptosis, causing the epitehlial cells to shed as
a protective measure (Choi et al., 2016). Furthermore, a detrimental
action of the chymase is in the course of glomerulonephritis where mast
cells are distantly found in the kidney capsule (Scandiuzzi et al., 2010).
In bronchial asthma, mast cell chymase impairs bronchial epithelium
integrity through degradation of cell junction molecules, i.e. occludin,
claudin-4, ZO-1 and E-cadherin in epithelial cells (Zhou et al., 2018). In
the intestine the expression and secretion of chymase will have effect on
the epithelial barrier function via protease-activated receptor (PAR)-2
activation and matrix metalloproteinase (MMP)-2 expression and acti-
vation (Groschwitz et al., 2013).
Tryptase is the predominant serine proteinase of mast cells and
heparin stabilizes the activity of the functional monomeric tetramer
(Pereira et al., 1998), where the four substrate pockets facing inwards
to form a narrow proteasome-like structure. Tryptase preferentially
targets “linear” proteins displaying a stretch of positively charged
amino acids and will cut after arginine (R) or lysine (K) in its three
amino acid target site (K/R+X + K/R). Physiologic targets for tryp-
tase include, e.g. PAR-2 (Molino et al., 1997). The narrow pore in tet-
rameric tryptase would not allow entry of bulky proteins and thus this
could explain that no or very low degradation of soluble Giardia pro-
teins was observed.
A screen for potential chymase and tryptase target sites of the 15
most abundantly secreted proteins from Giardia WB and GS tropho-
zoites (Ma’ayeh et al., 2017) identified several potential target sites in
each of the 15 secreted Giardia proteins. This suggests that most soluble
Giardia proteins lack accessible surface exposed extended target sites
for the mast cell specific chymase (Fu et al., 2017). Alternatively, re-
sistance to degradation can partly be explained by that sGPs directly
reduce the activity of chymase.
In summary, we here showed that sGPs do not cause significant
mast cell degranulation and that sGPs were not significantly degraded
by tryptase or chymase. The lack of degradation suggested that ESPs
and sGPs could inhibit the activity of the mast cell proteases. In line
with this observation sGPs induced a significant inhibition of chymase
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activity. In contrast, we found that ESPs and sGPs specifically increased
the mast cell tryptase activity, suggesting that as yet unidentified pro-
tein(s) in ESPs and sGPs may stabilize tryptase tetramers, thereby in-
creasing the tryptase activity. We now aim to identify and characterize
the Giardia-proteins providing the increased effects of the tryptase ac-
tivity. In addition, future studies using heat inactivation of identified
candidate proteins and EPSs as well as cathepsin inhibitors, e.g. E64,
would be interesting and could address if intact and properly folded
ESPs or enzymatic activities in the ESPs are required for the observed
enhancement of tryptase and inhibition of chymase.
Speculative, our result suggests that Giardiamay affect the intestinal
tissue via increased stability of tetrameric tryptase or direct enhance-
ment of tetrameric tryptase activity as well as via inhibition of chymase,
and this potential immunomodulation could be beneficial for Giardia
since mast cell tryptase has been shown to control intestinal para-
cellular permeability and the enhancement of tryptase activity may lead
to a leaky intestinal tissue. Finally, the inhibition of chymase may serve
to retain intestinal barrier functions and reduce chymase driven in-
flammatory symptoms. However, the exact roles of the different mast
cell specific proteases during giardiasis remains an open question and
will require extensive in vivo experimentation to be resolved.
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